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ABSTRACT 
 
Development and Validation of an Instrument to Predict Non-Adherence to Medical Treatment 
Regimens 
 
 
 
 Evaluation of the Health Adherence Behavior Inventory (HABIT) is described with data 
pertaining to reliability and validity.  The instrument was originally developed for use in a primary 
healthcare setting, to support the early identification of patients who are at risk for poor health 
outcomes and complications of chronic disease because of non-adherence to their healthcare 
provider’s instructions.   The items were refined from the original HABIT (DiTomasso, 1997) and 
drawn from various sources, including health risk assessments, health screening questionnaires, and 
nationally accepted standards for disease treatment and prevention.   
 The questionnaire consists of 50 items, 39 of which appear to load on one factor.  Items were 
analyzed, revealing two clusters, which yielded one Main Factor (Prevention Factor).  This factor 
represents positive health behaviors that have demonstrated a correlation with reduced risk for 
negative health outcomes.  These behaviors address one domain of the multifaceted problem referred 
to as non-adherence. 
 With respect to construct validity, the questionnaire correlated significantly with the widely 
used and reliable Health Risk Assessment developed by Lifestyle Directions, Inc.  The strong 
correlation with an established Health Risk Assessment suggests promise for further refinement of 
the scale, offering a briefer alternative to full risk assessment.  Through additional research, it is 
anticipated that a more comprehensive set of questions may uncover other key domains that offer 
valuable insight into the prevention and the treatment of non-adherence. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
It is estimated that in 2003, over 3 billion prescriptions were written by physicians in the 
United States.  Researchers estimate that between 12% and 22% of these prescriptions have never 
been filled.  Another 12% were filled but were not taken, and of those taken, better than half would 
have been discontinued within 1 year. (Ellis, et al. 2001)   The consequences of this problem are 
staggering, yet a single solution has yet to be clearly identified.   Non-adherence with medical 
treatment regimens is recognized as a significant healthcare issue and a risk factor for poor health 
outcomes (McDermott, 1997).   Creer (1996) refers to adherence as the “congruence between 
patient behaviors and advice or instructions provided by health care providers”.  For the purposes of 
this discussion, non-adherence will be defined as the absence of voluntary involvement by a patient 
in a mutually acceptable course of behavior to produce a desired preventive or therapeutic result 
(Meichenbaum & Turk, 1987).  Examples of such behavior would include failure to enter into 
and/or to continue a treatment program, keeping appointments, taking correct medications, adopting 
life-style changes, and following physician’s advice.   
The Cost of Non-Adherence 
Non-adherence with long term medication regimens has been estimated as low as 42% and 
as high as 60% (some higher), with an average of approximately 50% across disease states (Sackett 
& Snow, 1979; Haynes, 1985; Bayer Institute for Health Care Communication, 1996; 
Meichenbaum & Turk, 1987; Dean & King, 1999).  The Center for Health Policy Studies estimates 
that as many as 23% of nursing home admissions and 10% of hospital admissions in the United 
States each year may be due solely to non-adherence with prescribed medications.  (Wegner, et al. 
1995; Sung, et. al. 1998)   Adherence to asthma regimens, for example, has been estimated as 
                                                                                                                                                  Non-Adherence 
  
2 
standing between 2% and 100%, with an overall rate across studies at less than 50% (Milgrom, H., 
et al. 1996; Creer, 1996).   This is even more distressing in the face of pharmacologic advancements 
in the treatment of this illness which should improve patient management; instead of improvement, 
there is the unexplained increase in morbidity and mortality, which experts suspect may be closely 
tied to poor adherence (Creer, 1996). 
The impact of arthritis and related diseases is another example of enormous health care costs 
for individuals, their families, and the nation.  Every year, arthritis results in over 39 million 
physician visits and hundreds of thousands of hospitalizations, at an estimated cost of $15 billion.  
By the year 2020, experts estimate that 60 million Americans, or nearly 20% of the population, will 
be affected, and some 11 million will be disabled as a result (U.S. Dept. of Health and Human 
Services, Centers for Disease Control and Prevention, 1998).  Much of this could be moderated 
through the adoption of healthier lifestyles or through the use of therapy, as prescribed by a 
physician.  
The scenario is equally problematic in the area of heart disease.  According to the Office of 
Inspector General (1990), drug non-adherence with treatment for cardiovascular disease results in 
125,000 avoidable deaths each year in the United States alone.  In this report, Daniel Gerner, 
chairman of the Healthcare Compliance Packaging Council in Washington, D.C., reported that rates 
of compliance are about 46% among asthmatics, 33.5% for patients on antibiotic therapies and 53% 
among hypertensive patients.  Unfortunately, just over half of hypertensive patients are on any kind 
of therapy at all.  The American Heart Association (AHA) reported that hypertension alone killed 
42,565 Americans in 1997 and contributed to the deaths of about 210,000.  (AHA, 1999).  Since 
then these numbers have continued to rise.  The cost of cardiovascular diseases and strokes in the 
United States in 2005 is projected at nearly $393.5 billion, more than 3 times the estimated costs in 
1994.  This figure includes health expenditures (direct costs, which include the cost of physicians 
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and other professionals, hospital and nursing home services, the cost of medications, home health 
and other medical durables) and lost productivity resulting from morbidity and mortality (indirect 
costs).  In the case of hypertension the total cost is estimated at $59.7 billion. (AHA, 2003). 
The cost of chronic illness in the United States is tremendous, in terms both of quantitative 
and qualitative consequences.  The Task Force for Compliance in 1994 estimated that the combined 
direct and indirect costs of non-compliant patients for 1993 was over $100 billion, and in excess of 
$8.5 billion in hospitalization and physician costs; non-compliance was also responsible for over 
10% of all hospital admissions (McCarthy, 1998).   More recent studies reveal no significant 
improvements in this area.  Experts conservatively estimate that half of the 2 billion prescription 
medicines dispensed in 1998 were not taken as prescribed (Clepper, 1992; McCarthy, 1998).  
Maintenance therapies for asymptomatic conditions are especially prone to non-adherence.   
Other forms of non-adherence are not as well documented, but a 1985 study by Haynes 
found that 50% of patients did not follow referral advice, 7% did not keep follow-up appointments, 
and 50% suffering from chronic illnesses dropped out of treatment within one year.  Some clinical 
studies suggest that patients who fail to adhere to treatment regimens increase health care spending 
in the U.S. by $7 billion to $10 billion per year simply in increased hospital and physician costs 
(Cramer & Spilker, 1991).   In 1994, the direct annual costs attributed to noncompliance alone were 
estimated at $45 billion by Center for Health Policy Studies (Sung, et. al. 1998). 
The medical community, health maintenance organizations, and payers have called for better 
ways to help patients adhere to prescribed regimens and behavior changes (Guico-Pabia, C. et al. 
2001); (Eraker, Kirscht, and Becker, 1984).  Many attempts have been made to develop methods to 
enhance compliance with various interventions.  Unfortunately, the first evidence of non-adherence 
often occurs when the patient returns to the physician because the condition or illness has not 
improved or has worsened.  Only then can the physician even begin to suspect non-compliance 
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(McCarthy, 1998).  To date no comprehensive instrument is available to differentiate reliably, in 
advance of treatment, between patients who will be compliant and those who will not.   Such an 
instrument would offer healthcare providers the opportunity to intervene earlier in the treatment 
process by providing insight about potential barriers to adherence.   In anticipation of problems the 
patient may encounter, the physician could take immediate steps to lower, potentially, the patient’s 
risk of complications, to reduce side effects and associated costs of additional or stronger 
medication, to raise the individual’s quality of life, and improve therapeutic outcomes (Frederikson, 
1995). 
 
 
Non-adherence and Health Behavior Theories 
 
Numerous studies which examine non-adherence have been conducted, with varying degrees 
of success.  The overwhelming majority of these studies have been narrowly focused, examining 
between one to five specific factors, such as family or social support, patient education, 
provider/patient interaction, treatment complexity and dosing, access barriers, intelligence, and self-
efficacy, among others.   
Attempts to develop a theory of non-compliance have also generated several studies, 
including one example postulated by Fogarty (1997), which is referred to as the Reactance Theory.  
This theory draws upon the concept of psychological reactance to explain patient non-compliance 
with medical treatment.  A perceived threat by an individual to his/her freedom generates a 
motivational state aimed at recapturing the affected freedom and preventing the loss of other 
freedoms.  Thus the patients’ perceptions of threats to their freedom or control may induce non-
compliance.  In her work, Fogarty proposed three macrolevel non-compliance patterns, including 
length, complexity, and type of medical regimen.  She concluded that high rates of non-compliance 
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with complex and/or lengthy regimens may be at least partially explained by reactance theory, and 
she suggested, further, that there might be implications for  examining the physician/patient 
encounters more closely.  Interventions, she theorized, might be productive if the patients felt more 
in control of their conditions. 
In their review of the relationship between Social Cognitive Theory and health behavior,  
Baranowski, Perry, and Parcel (1997) summarize the constructs of Mischel (1973) and Bandura 
(1977) in a discussion of non-adherence, together with proposed intervention strategies.  Some 
examples of these constructs include environment, expectations, self-control, self-efficacy, 
reinforcements, and so forth.  They speculate that through the systematic identification of relevant 
domains or constructs associated with non-adherence, and the application of these domains to 
individual responses and behaviors, healthcare providers are better positioned to facilitate positive 
changes within their patient populations, and are able to do so at an earlier point in the treatment 
process.  The components of Social Learning Theory propose that the patient will not actively 
pursue change or positive health behaviors if he/she does not reasonably expect the ability to be 
successful.  Thus self-efficacy is an important concept with respect to predictive change.  Smoking is 
a negative health behavior that illustrates this concept.  (Glanz, Lewis, & Rimer, 1990).  Many 
people become discouraged after failed attempts to quit, which in turn decreases the likelihood of 
future attempts. 
In a discussion on the origins of the Health Belief Model, Rosenstock (1990) suggests that it 
is important to differentiate between intrinsic (an internal reason) and extrinsic (an external reason) 
motivations for change.  They hypothesize that self-efficacy is a stronger predictor of behavioral 
change among those with strong a perception of threat and a recognition of the benefits of taking 
recommended health actions.  “Perceived threat”, they stated, “is a sequential function of perceived 
severity and perceived susceptibility”.  People who deny their conditions will fail to acknowledge 
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the severity of the situations realistically, which in turn will affect their readiness to change.  The 
Health Belief Model presumes that a trigger will initiate other variables and behaviors into motion 
(Quine, Rutter, and Arnold, 2000).  One of the considerations believed to play a role in the patient’s 
actions include not only the perceived benefits of the treatment or behaviors, but also the barriers to 
obtaining or performing the necessary behaviors.  Barriers such as cost, convenience, and impact on 
self and family may negatively weigh in on the cost-benefit analysis of compliance. 
It is hypothesized that many factors can influence a patient’s ability and willingness to 
comply with a specific treatment regimen.  For example, adherence with medications is found to 
decrease under certain circumstances, such as the presence of side effects, perceived efficacy, the 
duration of medication use, the complexity of the regimen, and the relative cost of medications 
(Creer and Levstek, 1996).  Inadvertently poor (??) interactions between physicians or medical staff 
and patients or parents may also result in incomplete or inadequate instruction, which in turn leads 
to failure to understand side effects or to misperceptions that foster non-adherence (Creer and 
Levstek, 1996).  Other negative factors influencing patients may include lack of social support, 
memory decay, previous experiences, social stigma, apathy, co-morbidities (especially depression), 
lack of perceived benefits, and a general lack of reinforcement contingencies (Creer and Levstek, 
1996).    Research identifying causes of non-compliance attempts to reveal those who are 
liable to be non-compliant.  Much of this research is based upon models which were developed to 
explain health behaviors.  For example, the previously mentioned Health Belief Model (HBM) 
proposes that individuals are more or less likely to adhere to a treatment regimen if they believe that 
1) there is a threat to their health, 2) they are personally susceptible to negative consequences, 3) 
they have some control in averting a negative health consequence, and 4) they do not perceive 
barriers to performing the desired behavior (Wiebe and Christensen, 1997; Tiedje and Kingry, 
1992).   The HBM, which dates back to the early 1950s, is one of the earliest models developed to 
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help explain health behavior and it is still one of the most influential and widely used approaches 
today.  In 1993 DiMatteo, (et al.), studied the adherence of cancer patients; this was done in an 
effort to develop a scale to address elements of patients’ adherence.  The Adherence Determinants 
Questionnaire (ADQ) assessed 7 elements of patient’s adherence to medical treatment and 
prevention, including perceptions of interpersonal care, beliefs about susceptibility, beliefs about 
severity, perceived utility of adhering, perceived subjective social norms for adhering, intentions to 
adhere, and perceptions of supports available, including absence of barriers.  Past adherence and 
health value were also assessed.  In field settings, intentions to adhere were most highly correlated 
with the perceived utility of adhering.  Self-reported and objective measures of adherence were most 
strongly correlated with the presence of supports and the absence of barriers.   
In a study of 597 women with early stage breast cancer, Fink, et al. (2004) found that 17% 
of the patients stopped taking tamoxifen during the 2 year follow-up period.  Of these, 68% stopped 
taking it within the first 12 months.  Examining the subjects’ beliefs about therapy, the authors 
concluded that the ways in which the women perceived the risks and benefits of therapy were critical 
for sustaining adherence, and they recommended interventions designed to educate patients about 
the benefits and risks to discontinuance. 
Although these models of beliefs and perceptions of severity and susceptibility have been 
frequently studied and show promise, to date they have not been shown to correlate consistently with 
variances in health related behaviors.  (Abraham and Sheeran, 2000)   
Another model, based upon structural theories of personality, is the Five-Factor Model (17), 
incorporated in the NEO Personality Inventory.  This instrument has not been well studied, but 
purports to identify five dimensions of personality, including Extraversion, Agreeableness, 
Conscientiousness, Neuroticism, and Openness to Experience.  Of these, only Conscientiousness 
appears to offer potential as a predictor of health behaviors, though this is still only speculation.  
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Other researchers have attempted to evaluate adherence by patients with chronic diseases, utilizing 
other personality questionnaires, such as the Sixteen Personality Factor Questionnaire (16PF).  Such 
research has demonstrated limited success with similar constructs, such as Locus of Control and 
Self-Control (Wiebe and Christensen, 1997).    
Self-Regulation Theory proposes that a patient’s adherence behavior is closely tied to the 
physical symptoms and illness memories which interact in a way that triggers the compliance 
process.  (Leventhal, 1984).  To illustrate, in a study of kidney transplant patients, Siegal and 
Greenstein (1998) reported that the patients most likely to adhere to treatment regimens were 
“convinced” that their medications must never be delayed or missed, that they last in the body for 
less than 1 day, and that their physical symptoms interfered with the things they needed to do.  In 
contrast, the low, or “partial-compliers”, did not believe that the medication was essential, that it 
lasted longer in the body, and they perceived their physical symptoms to be milder than those in the 
“compliers” group.  
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The Multiattribute Utility Theory speculates that actions depend upon subjective values of 
specific outcomes.  The individual considers the probabilities and consequences of alternative 
decisions, along with the relative importance of each consequence to the final decision.  Ultimately 
these factors influence the person’s actions.   In the case of alternative health behaviors, it is 
speculated that the Multiattribute Utility Theory model has the ability to differentiate adherent and 
non-adherent patients.  However few studies have been conducted to evaluate this theory in applied 
health decisions.  (Carter, 1990)  The Multiattribute Utility Theory is best illustrated in consumer 
purchasing behavior.  Buying a car with airbags, for example, may cost more than the consumer 
would like to pay, and the purchaser must consider the probability and consequence of deciding to 
pay more or forego the option. 
Yet another theory on behavior change is the Attribution Theory developed by Weiner in 
1986.  Similar in theme to other health psychology models, this theory focuses on the human need or 
desire to understand or explain adverse events.  People want to make sense of their world and 
attempt to do so by looking for causal relationships.  In 2000, Byrns studied low back pain in the 
garment workers industry.  He found that those employees who attributed their pain to internal 
causes, such as knowledge of back safety, tended to feel less distress than those who believed the job 
itself was too difficult (external attributions).  According to Byrns, this belief of the former that their 
pain could be reduced through their own actions reinforced the workers’ motivation to adopt 
healthier behaviors based on a perception of their control of their particular circumstances.   
Other theories that have been proposed to contribute greater understanding to the reasons for 
non-adherence include components similar to those already mentioned.  For example, The Protection 
Motivation Theory framed by Rogers in 1975 underscores the persuasive value of fear 
communications; together with perceived self-efficacy, these may lead to cognitions and motivation 
for coping mechanisms and decisions to engage in protective behavior.  A practical illustration of 
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this theory is the relatively higher treatment compliance rate believed by some to be observed in 
patients with HIV.  In Western nations, the fear of HIV, along with mass communications related to 
prevention and treatment, were believed at one time to contribute to greater use of condoms in high 
risk populations and with better compliance with treatment among those already infected and 
diagnosed. (Catz, et al., 2000)  Recent literature reveals mixed results. 
Consumer Information Processing Theory (Rudd, et al. 1990) focuses on consumer choice 
and the availability of relevant information.  This model supports the idea that consumers’ decisions 
are directly related to each individual’s ability to process information (capacity), in combination 
with motivation, attention, and decision rules and processes.  The quality of the information and the 
consumer’s internal cost-benefit analysis is tied to other constraints such as time, difficulty, etc. in 
the decision making process.  At face value, this appears to make sense when applied to decisions 
such as financial investments, or the support of a particular political candidate.  Unfortunately, when 
applied to decisions about healthcare, this model may not always serve the patient’s best interests, 
particularly if he/she does not take the time necessary to make a fully informed decision.  This may 
be related to perceived difficulty in understanding the choices in healthcare decisions, pointing again 
to the importance of the physician’s role in properly educating his/her patient.   
Within the last two-plus decades, revised versions of older theories have also surfaced.  
These include the Media Advocacy Theory (1990); the Precaution Adoption Model (1993); and the 
Transtheoretical Theory (1982-1983).   Of these, the Transtheoretical Theory has received the most 
attention nationwide by stakeholders in the healthcare industry.  DiClemente and Prochaska 
developed this model, with the initial focus primarily on how people change addictive behaviors 
(although precursors of this stage model can be found as early as 1966).  (Prochaska, DiClemente 
and Norcross, 1992).  The premise is that all individuals go through various phases when making 
changes and that this process has certain,(?) defined stages related specifically to the person’s 
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readiness to change.  These dimensions of the change process are delineated in five phases, 
beginning with precontemplation, contemplation, preparation, action, and maintenance.  In the 
precontemplative stage the person has no intention to change in the foreseeable future.  As individual 
awareness is raised and the person initially considers change, he/she has entered the contemplation 
stage.  Thus in the case of health behaviors, a good illustration is the person who smokes cigarettes. 
This is the behavior most closely studied and most frequently referenced in literature on the 
transtheoretical model.  According to proponents of the theory, the smoker who thinks seriously 
about quitting, and in fact begins to investigate methods to quit, has entered the contemplation 
phase.  Once he/she joins a smoking cessation program, buys the nicotine patch, or other substitute, 
the person has entered the preparation phase.  Actually using the patch or participating in smoking 
cessation classes and stopping this behavior constitute the action phase. (Norcross, et. al., 1989)   A 
study by O’Connor, et al. (2004) was designed to test the hypothesis that patient readiness to change 
predicts future changes in glycemic control in adults with diabetes.  The results presented readiness 
as an independent predictor of change in HbA(1c) for patients with high functional health status, but 
not for patients with low functional status.  The authors recommended judicious use of the readiness 
to change assessment as a potential to improve care.  Considerable controversy exists over the lack 
of standardization of measures, of timeframes for stages, and of the exact predictive value of the 
model.  However, the theory has many supporters and several have adapted the model to specific 
uses, especially in healthcare, in which efforts to influence health behavior changes are becoming 
increasingly aggressive in response to rising costs.  Examples include a variety of disease 
management programs which incorporate one-on-one counseling interventions, such as patient 
reminders and education, and low/no cost treatment, each designed for the patient’s specific “phase” 
in the transtheoretical process of change.   
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 Although specific factors are speculated as contributing to non-compliance, the issue is 
generally considered to be a multi-factorial phenomenon and to date no comprehensive assessment 
tool is available to identify prospective patients at risk for non-adherence. Various theories, 
including those underlying the development of models such as the Health Belief Model (HBM), 
provide a valuable foundation for examining the correlates of poor adherence; however, the problem 
is not consistent across patients, and numerous factors may operate simultaneously in any patient at 
any point in time.  This is a significant challenge because the problems cannot be adequately or 
efficiently addressed until the underlying causes are identified and targeted.   
 
Non-adherence and related Psychological, Social and Clinical Variables 
 
From the Journal of Health Psychology, DiMatteo (2004) reported that a meta-analysis of 
patient adherence and social support has revealed a significant relationship between structural or 
functional social support and patient adherence to medical regimens.  Factors such as practical, 
emotional and unidimensional social support, family cohesiveness and conflict, marital status, and 
living arrangements were examined.  Practical support substantiated the highest correlation with 
adherence; marital status and living arrangements had modest correlations 
Sanz, Constable, Lopez-Ibor, Kemp, and David (1998) studied insight scales and their 
relationship to psychopathological, social, and clinical variables.  Their results supported the theory 
that psychopathology and clinical variables, particularly those related to insight, are related to 
attitudes towards treatment and subsequent compliance.  The implications for those with mental 
health issues are evident.  
In a recent study by Tucker, et al. (2004), the authors examined psychosocial mediators of 
antiretroviral non-adherence in HIV-positive adults with substance use and mental health problems.  
This challenging population included 1,889 HIV positive patients on antiretroviral therapy (ARV).  
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The purpose of the study was to investigate whether or not non-adherence to ARV could be 
explained by difficulty in getting the treatment and/or negative attitudes toward ARV medications.  
Difficulty in getting the medications and a poor fit with lifestyle were documented as the two most 
significant mediators.  Poor fit with lifestyle referred to heavy use of alcohol and narcotics, which 
compromised memory, motivation, and social support. 
With the advent of Medicaid and Behavioral Managed Care, physicians and mental health 
professionals have more aggressively sought ways to increase patient compliance and appropriate 
utilization of services.  One area of focus studied by Moore-Greene (2000) involved an attempt to 
standardize social indicators to enhance medical case management, including compliance.  The 
result was the development of what the author referred to as “life indicators”, which she loosely 
defined as bio-psychosocial problems, with emphasis on environmental situations such as poor 
access, and lower SES; these appeared to be moderately correlated with poor compliance and other 
negative health measures.  She concluded that life indicators could be readily incorporated into a 
medical case management model to target noncompliance and inappropriate utilization.  More 
recent research suggests that doubling co-payments for prescriptions leads to increased use of 
emergency department visits (17%) and increased hospital days (10%) for the sentinel conditions of 
diabetes, asthma, and gastric acid disorder.  (Goldman, et al., 2004). 
In addition to financial barriers, patient characteristics such as age and education have also 
been studied.  Huyser, et al. (1997) examined factors affecting adherence to rehabilitation 
interventions for individuals with fibromyalgia.  The subjects were followed through a six-week 
training program, with questionnaires and physical exams.  Although treatment factors revealed a 
modest correlation with overall adherence, the best model for predicting adherence suggested that a 
subject’s age and education were the strongest influences. 
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In a study to evaluate the correlates of compliance with follow-up appointments and the 
filling of prescriptions following an emergency room visit, only 45% of more than1300 patients at 
an urban hospital could recall being advised to take a medication; of these, 12% reported that they 
did not obtain the medication.  Of those who indicated that they were given follow-up appointments, 
33% said they missed their appointments.  Although lack of insurance was an independent correlate, 
dissatisfaction with discharge instructions was also identified as a correlate of not filling 
prescriptions (Thomas, et al., 1996).   Extensive evaluation of the data to assess the underlying 
causes of dissatisfaction was not presented. 
At the University of Pittsburgh, a recent study to explore the relationships between adherence 
with a medication regimen for lowering serum cholesterol and several domains of psychological and 
cognitive functioning, researchers found that conscientiousness and IQ were robust predictors of 
adherence in hierarchical regression analyses.  Depression and anxiety, mental flexibility, and 
visuospatial-constructional ability were less robust but still statistically significant correlates of 
adherence.  (Stilley, et al. 2004)   
As healthcare costs continue to rise, Health Insurance Organizations (HMOs, PPOs, etc.) 
and other payers (employers) continue efforts to understand human behavior more fully and to 
discover ways to influence individuals to reduce health risk factors.  Many studies have looked at 
specific interventions designed to motivate individuals to practice preventive health care.  One such 
study was conducted to evaluate the effect of a cash incentive to improve adherence to preventive 
health behaviors, specifically to encourage obtaining an annual physical.  For 3 consecutive years a 
cash incentive of $60 was offered to each individual in a small insured population (1500 people) 
who received a complete physical examination within the previous 12 months.  On average, 26% of 
the eligible participants took advantage of the screening and the $60 incentive. (Manatee County 
Government, 2002).   
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In a study on compliance, Haynes (1985) also reported that adherence to treatment regimens 
was found to be associated positively with the physician’s ability to make the patient feel 
understood; there was also a positive association with the patient’s perceived support and ability to 
negotiate, feeling as if he or she were collaborating with the physician in the treatment.   This adds 
credence to the importance of self efficacy in the patient’s general motivation for adherence.  In 
several studies involving patients with cancer, schizophrenia, and diabetes, the physician-patient 
relationship has also been demonstrated as an important factor in therapeutic outcomes (Smith and 
Thompson, 1993). 
Steiner (1994) examined several aspects of non-compliance to help understand essential 
factors that influence this behavior.  The results noted many opportunities for misunderstandings 
that can and do occur during a healthcare episode.  They reported that the essential factors 
influencing compliance included patient/provider interaction and thorough drug education, usually 
focused on benefits and disadvantages (particularly where side effects were also fully explained). 
In another study on understanding communication as a variable, Enguidanos (1997) studied 
language as a factor which affects compliance following an emergency room visit.  The objective 
was to focus on the English language versus the Spanish language as significant variables.  Four 
additional socioeconomic factors were also compared. They found no correlation between language 
and compliance, but they did report that having a primary medical doctor prior to the Emergency 
Department visit was positively correlated with follow-up compliance; this was the only significant 
socioeconomic variable irrespective of language ability.   
In a similar attempt, Thomas, et al. (1996) found that not having made an appointment 
before leaving the Emergency Department was an independent correlate of missing follow-up 
appointments.  In addition, the absence of insurance and dissatisfaction with discharge instructions 
were reported as independent correlates of not filling prescriptions.  These studies are similar to 
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other studies which underscore the value of consistent and reliable information sharing between 
providers in order to offer a more cohesive approach to individual care. 
Putnam, et al. (1994) found that a commitment-based intervention was effective in 
significantly improving patient adherence to medical regimens.  Based upon a 10 week antibiotic 
regimen, subjects were asked to give verbal and written commitments for adherence and they 
completed tasks designed to increase their investments in a medication program.  The concept 
resembles patient contracting in psychological counseling treatments.  During treatment, 
unannounced pill counts were conducted and structured tasks were assigned.  The authors concluded 
that the conscientiousness of the participants was triggered by the verbal and written commitment, 
thereby decreasing the likelihood of premature termination of therapy. 
Although many studies have analyzed self efficacy, patient education, and provider 
communication, other studies which examine a patient’s mental status have also revealed some 
interesting outcomes.  DiMatteo (2000) evaluated the associations between anxiety and non-
compliance and depression and non-compliance, as potentially independent factors.  Anxiety proved 
to be relatively insignificant as the subjects’ averages were low; however, the relationship between 
depression and non-compliance was substantial and significant.  They concluded that compared with 
non-depressed patients, the odds are 3 times greater that depressed patients will be non-compliant 
with medical treatment recommendations.  The authors suggested that further research is warranted 
among patients who might not be adhering to medical advice in order to explore the value of early 
recognition of depression as a risk factor for poor outcomes.    In similar work, Delgado (2000) 
concluded that the complex nature of noncompliance includes rational and intentional decisions 
based on many beliefs, which in turn may be significantly colored by depression.  The author 
concluded with recommendations to develop strategies directed towards the effective education and 
treatment of depression, emphasizing collaboration between the patient and the physician. 
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Researchers at the Washington University School of Medicine in St. Louis, Missouri also 
found that elderly patients with coronary artery disease who were depressed were significantly less 
likely to adhere to their treatment regimens than their non-depressed counterparts (Carney, et al., 
1995). 
 
Non-adherence, Depression, and the Elderly 
 
Nikolaus (1996) structured a study on the elderly to identify problems with medication 
compliance during and after hospital stays.  They concluded that logistical problems such as 
difficulty opening and removing tablets from commercial packages presented serious challenges for 
these patients and recommended routine testing of packages during a hospital stay.  They also 
reported that management of medication should be taught and supervised within the first few days 
after discharge from the hospital.   Similar results were found by Cramer (1998), in a study to 
understand the role of packaging aids and the monitoring of compliance in the elderly. 
A data analysis by a large health insurance organization on members over 50 years of age 
revealed that age, existing health status, and education seemed to be correlated with adherence to 
multiple healthy lifestyle factors.  For individuals 50-64 years of age, all three factors appeared to be 
statistically significant.  For seniors 65 years and older, having a college degree was the only 
statistic(?) significant with healthy lifestyles.    
Because seniors are the largest single demographic group of healthcare consumers, extensive 
research has been invested into ways to improve long-term compliance for chronic diseases.  Liu and 
Park, (2004) conducted a study to examine whether or not forming detailed implementation plans 
for achieving a goal improved older adults’ adherence to a health behavior.  They concluded that 
continued reinforcement, practice, and training significantly improved the subject’s adoption of 
positive health behaviors.   
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Franson and Smith (1998) published an article which reviewed the extent of non-compliance 
in older adults who take psychotherapeutic agents.  Their review found that, in addition to the 
patient/provider relationship, belief in the efficacy of the medication, patient education, and the type 
of psychotherapy were also influential factors.  Although it was not formally assessed, the authors 
inferred the importance of a positive therapeutic alliance. 
 In a separate study of older adults, compliance with adult preventive care guidelines was 
conducted, revealing that high knowledge scores, accompanied by recommendations based on 
patient history, knowledge of preventive care guidelines, and high self-perceived effectiveness were 
independently associated with self-reported preventive care efforts.  Female gender also appeared to 
be modestly associated with greater attention to preventive care (Ely, et. al., 1998). Recently, 
many more studies have been undertaken to focus on senior Americans.  A rapidly aging population, 
coupled with double digit healthcare inflation has drawn much attention in the political arena.  In a 
more recent study conducted by Hughes (2004), the author found that older patients may 
deliberately choose not to adhere to medication (intentional non-adherence) to avoid adverse effects 
of the medication.  In addition, when further questioned it became apparent that the patients selected 
which medication to skip based upon symptoms;  consequently, non-symptomatic conditions such as 
hypertension were less likely to be addressed than more painful or symptomatic conditions, such as 
migraine or arthritis.  
 
Inappropriate Use of Medications 
 
Misuse of medications is another major cause of morbidity and mortality.  Few studies have 
examined the frequency of, and factors associated with, discrepancies between what doctors 
prescribe and what patients actually take.  Bedell, et al. (2000) conducted a 4 month study in private 
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practices affiliated with an academic medical center in Boston.  A population of 312 patients from 
practices of 5 cardiologists and 2 internists were compared by examining medication bottles with 
medical records.  Although findings could not consistently identify discrepancies across classes of 
medications, the types of errors included: patients taking medications that were not recorded, 
patients not taking enough of a prescribed medication, and patients taking more medication than 
indicated.  The authors concluded that discrepancies among recorded and reported medications were 
quite common, across all drug classifications.  Older age and polypharmacy (complexity of 
treatment regimen) were reported as the most significant correlates of discrepancies in general.  The 
article concluded with an urgent recommendation to address these causes.  Disease management 
companies understand the dynamics of these issues and those who work with seriously ill 
populations employ numerous practical interventions, such as patient diaries, alarm watches, and 
pill holders, which reflect recent learnings in this field. 
Conditions or treatments which are generally considered non-life threatening or palliative in 
nature are less (often)?? (seriously)??? studied.  For example, though not generally considered life-
threatening, non adherence with Hormone Replacement Therapy is estimated to be between 70% 
and 91% for women from 40 to 60 years of age (Hurley, et al., 1998).  The problem resides not so 
much in who takes it versus who does not, but who begins and then stops abruptly without telling 
her physician.  This type of behavior supports susceptibility theories such as the Self-Regulation 
Theory and the Health Belief Model, suggesting the perceived severity of the condition and relative 
susceptibility to negative consequences is relatively low. 
 
 
Non-adherence and Asthma 
 
Data from the National Health Interview Survey (1980 – 1990) reported that the age-
adjusted prevalence rate of self-reported asthma increased by 38% over this time period.  
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Additionally, Taylor found a significant increase in the prevalence of asthma in children younger 
than 18 years of age (from 3.2% in 1981 to 4.3% in 1988) (Creer & Levstek, 1997).  There are 
many thoughts about the cause of this increase, such as air pollution, inner-city congestion, and the 
need for better identification and diagnosis.  The corresponding physician visits for asthma increased 
from 6.5 million to 7.1 million during the same timeframe.  What is more alarming, however, is the 
sharp increase in deaths from asthma, which rose 46% between 1980 and 1989 (Creer & Levstek, 
1997).  Given the rapid development of newer and more effective treatments for asthma, the increase 
in deaths is particularly distressing and underscores the importance of treatment adherence, 
specifically in manageable conditions such as asthma.  Non-compliance with prescribed medical 
regimens and an inability to use medications properly, especially inhalers, has been identified as 
possible causes of increased morbidity and mortality associated with asthma (Legorreta, 1998). 
In a study of health beliefs and compliance with asthmatics, Chambers, Markson, Diamond, 
Lasch, and Berger (1999) found that patients were more likely to report regular use of inhaled 
corticosteroids if they saw themselves as active participants, meaning that they collaborated with 
their physician in treatment and they viewed asthma as a serious illness.  Their beliefs about the 
consequences and their perspective on personal control over the disease supported the concept and 
importance of patient education and of shared decision making to achieve better outcomes in the 
treatment of asthma.  This also lends credibility to the concept of self-efficacy and the constructs of 
Social Cognitive Theory as applied to patient adherence. 
 
Non-adherence and Kidney Disease 
 
Much of the literature on treatment compliance has focused on attributions, health beliefs, 
and emotions as influencers of adherence.  In a separate study on these variables with hemodialysis 
patients, Friend, et al. (1998), found that of these three potential factors, attributions appeared to 
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play a more significant role than either health beliefs or emotions, though none significantly 
predicted both absolute fluid levels and fluid adherence.  Health beliefs predicted changes in fluid 
adherence, but attributions predicted absolute fluid adherence.  Negative emotions showed no 
correlation with absolute fluid levels or changes in fluid adherence. 
 
 
Non-adherence, Heart Disease and Hypertension 
 
A study involving cardiac patients found that physicians ranked hospital recommendations 
as one of the most important sources of patient information and one of the most important influences 
on patient compliance, stating that patients who were recently hospitalized were much more likely to 
follow treatment regimens, post-discharge, than those who had not been hospitalized.  The results 
did not follow the length of time that patients followed treatment post-discharge nor was further 
investigation conducted to evaluate the patient’s interpretation of the significance of hospitalization, 
nor whether the hospitalization was the primary influential factor.   Nevertheless, the physician’s 
perceptions of the patient’s attitudes regarding compliance are recognized as fertile ground for 
research.  (Feely, J.  1999). 
Steiner (1994) conducted a three-part review on patient compliance in an effort to outline the 
term compliance.  The results focused on the complexity of medical regimens, and emphasized the 
fact that it is the patient and physician interaction which seems to determine more heavily the 
likelihood of compliance, especially when (?) symptoms are not evident.  Similar results were found 
by Sung, et al. (1998) in a study of patients with hyperlipidemia.  In this asymptomatic condition, 
factors that appeared related to poor adherence included gender (females were lower in compliance), 
patient/physician communication, complexity of regimen, side-effects, perceived health status, and 
comorbidities.  Patients who reported previous histories of good compliance were also more likely to 
adhere to their treatment regimens.  The data did not offer an explanation for the differences in 
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gender, although it is worth noting that many medications for hypertension and other heart 
conditions are contraindicated in women of child bearing age. 
In a study at the University of Southern California, 86% of new antihypertensive drug 
therapy patients interrupted or stopped purchasing medication during the first year.  Each of the 
patients who interrupted therapy used an additional $873 for health care in that 12 month period.  
The higher costs were primarily due to increased hospital expenditures (Cramer, 1997).  Ischemic 
heart disease is one of the major causes of morbidity and mortality in the United States, representing 
over 20% of all deaths in 1996 (Sung, et al., 1998).  Many of the risk factors for this chronic 
condition are well established and preventable, i.e. diets high in cholesterol, hypertension, smoking, 
physical inactivity, obesity, depression, and diabetes.  Moreover, the Multiple Risk Factor 
Intervention Trial (MRFIT, 1998) has documented the fact that persons with combinations of risk 
factors such as hypertension, hyperlipidemia, and diabetes are at higher risk for cardiovascular 
disease and associated mortality (Chang, et al., 2001).  If physicians were able to influence patients 
to adopt positive health behavior changes, the necessity for medication could be significantly 
reduced, as would unnecessary hospitalizations and physician visits.   
 One in four adult Americans has high blood pressure and nearly a third do not know they 
have the condition.  Nearly 15 percent of individuals with hypertension are not on any type of 
therapy (special diet or drugs) and 25 percent of those on therapy are not taking adequate 
medication nor are they using measures to achieve desired blood pressure goals.  Roughly 50% of 
hypertensive patients who have experienced a cardiovascular event discontinue cardiovascular 
rehabilitation within the first year of the event; between 16% and 50% discontinue medication 
within the first year; and greater than 79% relapse and begin to smoke again within the first six 
months of an event (Burke and Dunbar-Jacob, 1997).   Hypertension is easily detected and usually 
controllable.  Non-Hispanic blacks (particularly males) and Mexican Americans are more liable to 
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suffer from high blood pressure and have a greater mortality rate, than are non-Hispanics.  People 
with lower educational and income levels also tend to have higher levels of blood pressure.  The use 
of medication and lifestyle modification (including diet, smoking cessation, and exercise) are well-
established behavior changes that can help control high blood pressure.  Controlled hypertension 
reduces the risk of other cardiovascular disease and resulting healthcare utilization.  However this is 
only true for patients who are cooperative and responsive to treatment, i.e. adherent to treatment 
and/or medication.  Research has revealed that patients have high adherence if they sustain their 
routine for at least 6 months (American Heart Association, 1999).    
 Meta-analyses indicate that patients with mild-to-moderate hypertension can benefit 
significantly from even modest blood pressure reductions.  A reduction of 5mm Hg in diastolic 
pressure would reduce mortality from stroke by 40% and from coronary heart disease by 14%, 
(Rudd, Ahmed, Zachary, Barton, and Bonduelle, 1990).  One of the key challenges with 
hypertension is to convey the severity of the condition in terms that influence the patient’s attitude 
and motivation. 
 
 
Non-adherence and Communicable Diseases 
 
Numerous studies have linked social support to better medication adherence among illness 
groups, but few have examined potential mechanisms for this relationship.  Gonzalez, et al. (2004), 
in their research on social support, positive states of mind (PSOM), and HIV treatment adherence in 
men and women, found that depression and PSOM were highly correlated with better adherence, 
whereas higher depression scores related to non-adherence.   
It is widely recognized that adherence to antiretroviral therapy is critical to long-term 
treatment success, yet rates of adherence to antiretroviral medications are also frequently 
subtherapeutic.  In a United States study of HIV patients, compliance with a complex treatment 
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regimen was assessed to determine modifiable conditions associated with suboptimal adherence, 
including how well clinicians predict patient adherence.  The findings (Patterson, et. al. 2000) 
indicated that a clear and significant relationship between compliance and clinical outcomes was 
evident, (i.e. virologic failure and treatment compliance); however, the underlying cause for poor 
compliance was not apparent.  Moreover, physicians and nurses could predict adherence correctly in 
fewer than 50% of the cases. Existing studies on compliance suggest an inverse correlation between 
the number of medications that patients take and the degree to which they comply with their 
treatment regimens.   
Bedell, et al. (2000), studied compliance with complex regimens of HIV patients and also 
concluded that dosing is a relevant consideration, with greater compliance typically associated with 
fewer doses per day in some subsets of patients.  This may offer some explanation about the reasons 
that some individuals with complex diagnoses fail to adhere to medication treatment regimens.  
However, this behavior pattern is not consistently observed in HIV patients who are generally still 
more compliant than average, yet maintain very complex treatment regimens.  This may lend 
credence to the Health Belief Model, which attributes, to some degree,  adherence to the individual’s 
perceived threat (HIV is viewed as a very deadly disease) compared with their perceived ability to 
manage it (medication is seen as the only hope of slowing disease progression). 
A study was conducted by the University of California, San Francisco (UCSF), Center for 
AIDS Prevention to learn more about the factors that motivate or deter patients from multi-drug 
therapy.  Through in-depth interviews the researchers learned that patients who were not on therapy 
most often indicated they would be motivated to start treatments if they experienced a decline in 
their health status (fear) and/or if they received strong recommendations from their physicians to do 
so (Key, 1998).  Here again, the patient/physician relationship appears to be critical, although 
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perceived loss of freedom (patient denial) and co-morbidities such as depression may also be very 
important factors. 
Similar research results were reported in a 2004 study by Reynolds, et al., which examined 
beliefs about antiretroviral therapy and psychosocial characteristics of HIV-positive persons.  
Among a subset of 325 patients reporting current use of medications (nonantiretrovirals) during the 
prior month, depression was the strongest correlate of non-adherence.  The most common reasons 
given for non-adherence to the medications, in descending order, were “simply forgot”, “away from 
home”, and “busy”.  The authors concluded that personal and situational factors such as depression, 
stress, and lower education were associated with less certainty about the potential for treatment 
success and with the perceived ability to adhere. 
In the March, 2000 issue of Health Psychology, Catz, et al. published their study on patterns, 
correlates, and barriers to medication adherence among persons who were prescribed new treatments 
for HIV disease.  The study included 63 men and 9 women on highly active antiretroviral therapy.  
Subjects completed measures of medication adherence, of psychological characteristics, and of 
barriers to adherence.  After 3 months, nearly 33% of the subjects had missed doses during the 
previous 5 days.  Depression, side-effect severity, self-efficacy, and social support were the most 
significant correlates of poor adherence. 
Another study with a homeless population examined the effect of cash incentives to improve 
adherence to tuberculosis preventive therapy.   An intervention group was compared with “usual 
care”, and the results showed a significantly better compliance rate in the group that received the 
monetary incentive ($5 biweekly cash) (Tulsky, et al., 2000).   Although the results of this kind of 
intervention may be intuitive in this unique population, these kinds of studies offer useful 
information and lay the foundation for continued research on the domains of non-adherence and the 
interventions that show promise. 
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Non-adherence and Preventive Care 
In addition to researchers, employers have also attempted to understand how and why people 
comply with healthy behavior regimens, particularly with respect to preventive care.  Weinberg 
(1997) reported that eliminating a common barrier, specifically access, played a significant role in 
facilitating a higher compliance rate with recommended mammography guidelines.  Employees were 
offered mammograms at the work-site, resulting in 89.5% of women receiving at least one 
mammogram, and 44.6% practicing monthly self-exams.  Though not significant, the compliance 
rate favored Caucasians and women with a family history of breast cancer, suggesting that the 
relevance (perceived threat) of the disease was also a factor.   In 1995, Friedman, et al. found that 
utilizing the Health Belief Model, analyses of behaviors and intentions to obtain mammograms 
suggested two strong predictors of breast cancer screening – physician recommendations and 
perceived barriers.   
A meta-analysis of studies evaluating the effect of patient education and counseling for 
preventive health behaviors conducted in 1997 by Mullen, et al., revealed that education and 
counseling conducted by the primary care provider does help patients adopt healthier lifestyles 
across many behaviors; however, emphasis was placed upon the types of behaviors changed, and 
recognized that addictive behaviors such as smoking and alcohol abuse were more challenging 
issues. 
In summary, there is significant and relevant literature which indicates the degree of concern 
surrounding the issue of non-adherence, including the magnitude of the problem.  This problem 
contributes substantially to the high costs of healthcare in the United States, not only through poorer 
health outcomes, morbidity, and death, but also indirectly in reduced quality of life, disability, and 
intangible measures of productivity.  A better understanding of the fundamental issues of non-
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adherence as well as their key contributing factors is essential to improving the long term health 
status of Americans. 
 
 
Rationale   
The primary point of care in the healthcare delivery system takes place in the physician’s 
office.  The principal provider/patient interaction represents the initial step in each unique episode of 
care.  What the physician does within practice is really involved with behavior prescriptions, such as 
eating, sleeping, exercise, and medication.  However, the physician usually does not target non-
adherence and often underestimates it.  This may be due to the fact that there are so many possible 
factors contributing to non-adherence that it is difficult to know which factors are operating for any 
given patient at a given point in time.  (Claydon, Efron and Woods, 1997).   For example, in a meta-
analysis conducted by Lisper, Isacson, Sjoden, and Bingefors (1997), the effects of patient education 
revealed that behavior-oriented instructions concerning the use of drugs (based on the patient’s own 
daily routines) were more likely associated with better compliance because the information was 
personal and specific.  Without delineating possible reasons for compliance, however, therapy 
becomes less focused and may be only partially effective, if effective at all.  If the constraints placed 
upon a physician’s time within our fractured healthcare system are included, the ability to identify 
prospectively or to react to patient’s behavior is even further compromised.  To the extent that the 
patient does not comply with his/her prescribed regimen, numerous, additional outpatient visits 
and/or hospitalizations may be necessary, compromising the quality of life for the patient, while 
adding to increased financial burden for the patient and healthcare system alike.  The result is 
significant and additional, but often avoidable, costs to society, to families, and to the individual’s 
quality of life.  As previously stated, non-adherence is a serious problem with potentially lethal 
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consequences.  Non-adherent patients may allow a disease to progress, and may require more 
invasive procedures, and more aggressive medications. When a physician understands the adherence 
issues that may affect a specific patient’s likelihood of complying with the treatment regimen, he/she 
is better prepared to offer the appropriate support at the beginning of the treatment process in order 
to facilitate better outcomes.  Approaches to improve adherence, such as those outlined by Creer 
(1996) and Chambers et al. (1999), suggest that by identifying patient’s issues, by altering treatment 
regimens and by applying behavioral techniques, the physician is able to influence outcomes 
positively.   
In the absence of reliable and practical methods to predict which patients will not adhere to 
their recommended treatments, physicians and other healthcare providers are left with their own 
judgments.  Frequently these judgments are based upon experience, either with those particular 
patients, or in general over time with multiple patients and conditions.  This approach leaves both 
the provider and patient vulnerable to the consequences of non-adherence.  An instrument that 
reliably predicts patients’ health behavior problems would provide a profile of factors contributing 
to non-adherence.  A tool of this nature would be invaluable in aiding the physician in the selection 
and implementation of appropriate interventions, which could ultimately lead to lower healthcare 
costs, higher quality of life, and a lighter burden of illness for all those who share the costs of poor 
health outcomes. 
 
Purpose of the Study 
The purpose of this study is to develop and validate a self-report screening instrument with 
valid and reliable psychometric properties so that it may be useful to identify those prospective 
patients with chronic disease who are less likely to comply with their medical treatment regimens.  
The framework for this instrument is the Health Adherence Behavior Inventory (HABIT) developed 
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by DiTomasso in 1997.  The original questionnaire was initially used by DiTomasso and colleagues 
to assess medical patients in an urban medical center.   Patients who failed to progress as well as 
anticipated in their treatments, and who were less compliant with their physicians’ instructions, 
appeared to exhibit similarly poor lifestyle habits.  The need to address these issues earlier in the 
treatment process inspired the use of screening questions to elicit relevant information for the 
primary care and mental healthcare providers.  This information proved useful in the early 
identification of problematic issues surrounding the patients’ behavior and ultimate health outcomes.  
The questions evolved from observations made by the healthcare team regarding patients who were 
observed to be or who were suspected to be non-compliant.  Specifically, the original items were 
intended to provide a brief but useful screening for positive health behaviors that were consistent 
with adherence and with better health outcomes.  Hypotheses concerning the utility of this 
instrument suggested that it would ultimately be brief, reliable, and be able to differentiate the non-
compliant patient from the compliant patient.  This led to further refinement of the items and a 
consideration for more rigorous evaluation and empirical study.   The present study was proposed to 
examine the psychometric properties of the HABIT, specifically to assess the construct validity, the 
internal consistency, and the factor structure of the questionnaire.  Construct validity was assessed 
by comparing the HABIT with a well documented and validated Health Risk Assessment by 
Lifestyle Directions, Inc.  For the purposes of this study, medical treatment regimen was confined to 
treatment protocols involving medication, exercise, and diet, with emphasis on medication.  Chronic 
disease was limited to specific diagnoses indicative of hypertension. 
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Research Question/Hypotheses 
 
The research question for this study was based on the idea that it is possible to predict non-
adherence in a medical patient population.  The hypothesis for this study presumed that individuals 
who are routinely non-adherent with medical treatment regimens tend to possess similar state/trait 
characteristics so that they can be identified in a practical and efficient manner (i.e. Questionnaire) 
to facilitate interventions by a professional healthcare provider.   
The research hypotheses were as follows:  
1.  The HABIT would possess content validity as established by an expert panel of 
healthcare professionals.   
2.  The HABIT would possess construct validity as demonstrated through factor analysis.   
3.  The HABIT would demonstrate internal consistency reliability.   
4.  People who were rated as less likely to comply with a prescribed treatment regimen 
would score significantly differently on the HABIT from those who were rated as more likely to 
comply with similar treatment regimens.  The degree of compliance would be measured by the 
following possession ratio calculation: 
Days Fill  
Ratio  = 
# of days in the previous 6-12 months for which the subject had recorded filled Rx  
# of days in the previous 6-12 months for which the subject had a recorded Rx 
 
The closer this ratio to “1”, the greater the degree of compliance with medication (a ratio of “1” 
would indicate that the subject had sufficient medication for an entire prescribed period).  It was 
anticipated that the results of this study would reflect a positive correlation between the scores on the 
Health Adherence Behavior Inventory (HABIT) and the Days Fill Ratio/Possession Rate. 
5.  There would be a negative correlation between the number of self-reported, positive 
health behaviors on the HABIT and blood pressure level. 
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CHAPTER 2 
METHOLODOGY 
 
 
Subjects 
 The subjects for this study were randomly selected from a population of eligible volunteers 
who presented at one of three pharmacies to receive a prescription for the treatment of hypertension.  
Subjects could be male or female and between the ages of 18 and 65.   
 A total of 300 subjects with completed surveys and screenings were required to complete this 
study as designed.  Only subjects who had been diagnosed with hypertension within at least the prior 
6 months and were currently being prescribed medication to treat hypertension were accepted into 
the study.  The subjects were queried to confirm the fact that they consistently filled their 
prescriptions with the same pharmacy. 
 Subjects may have had other concomitant conditions, provided these conditions did not 
preclude the subject from voluntary participation or render the subject housebound or bedridden. 
Participation was voluntary and subjects had to be willing to provide consent in writing by returning 
a signed consent form.   Subjects were free to withdraw from the study at any time. 
Participants were also required to understand and respond in English, utilizing, at a minimum, 
language ability at an 8th grade reading level. 
 Interested volunteers who were participating in other studies, including, but not limited to, 
clinical research trials, behavior modification studies, health surveys, or disease management 
studies, were not accepted into the study.  Patients who were institutionalized or hospitalized were 
also excluded from the study. 
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Design 
 This study employed a correlational research design to assess the psychometric properties of 
the Health Adherence Behavior Inventory (HABIT). 
 
Description of Instruments and Measures 
 Health Adherence Behavior Inventory (HABIT)   The Health Adherence Behavior 
Inventory, (DiTomasso, 1997), is a 50 item, dichotomous questionnaire, developed by DiTomasso 
for use in primary care settings. (see Appendix B)  The original questions were designed and 
delivered by healthcare providers in an ambulatory setting in an effort to uncover useful information 
to support an individual patient’s treatment progress.  The HABIT includes items that describe 
ordinary health-related behaviors, “habits”, such as following physician’s advice, getting 
prescriptions filled as soon as they are received, limiting intake of fatty foods, avoiding smoking, etc.  
The respondents are asked if the described behavior is generally true or not true of their own 
behavior.  Responses correspond with a numerical value:  (True = 1, False = 0).  A total score is 
then calculated by adding the response values from all completed items.  Most of the items are 
presented in the affirmative, such as “I limit the amount of sugar I consume”, or “I eat enough fruits 
and vegetables”.  Three of the 50 items are framed in the negative, meaning that the item describes a 
negative behavior or attitude, such as “People tell me I am a couch potato”.  These items are reverse 
scored.  It was anticipated that a higher score on the HABIT (indicating frequent practice of positive 
health behaviors) would correlate to a lower score on the Health Risk Assessment (reflecting lower 
risk of developing a disease). 
Health Risk Assessment. (HRA)  The Lifestyle Directions (LDI) HRA is an established 
health risk assessment that has been widely used for more than 20 years to measure risk of disease.    
The questionnaire has been well studied and correlates highly with direct medical costs and 
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utilization claims data.  (see Appendix C)  The HRA includes 113 items that solicit health-related 
history, behaviors and attitudes, as well as biometric screening values (to be entered by a clinician 
upon completion of blood screening and biometric measures).  The number of questions and 
categories are broken down (?) as follows:  (demographics = 3), (medical history = 38), (physical 
health = 9), (dietary habits = 10), (lab values = 7), (screening history = 3), (personal habits = 11), 
(attitudes on health = 6), (medications/drug use = 15), (exercise attitude = 1), (women only health = 
7), and (men only health = 3).  The HRA is a validated instrument with a proprietary algorithm 
(owned by Lifestyle Directions, Inc.) which is applied to all responses.  The analysis of responses 
yields a percentile score of “Overall Health Risk”.  The percentiles range from minimal risk (0% - 
25%), to moderate risk (26% - 50%), to major risk (51% - 75%), to severe risk (76% - 100%).   It 
was anticipated that a lower Overall Health Risk score (percentile %) would correlate with a higher 
numerical score on the HABIT.   
          The LifeStyle Directions, Inc. HRA is one of the oldest and most frequently utilized HRAs on 
the market.  A substantial study comparing HRAs was published in 1987 by Smith, et al. in the 
American Journal of Public Health, in which 41 HRAs were compared in terms of their validity in 
predicting risk of future coronary heart disease.  The study classified the HRAs into five categories, 
depending on their science-base and method of scoring.  The morbidity and mortality based HRAs 
required computer scoring.  The others could be scored by hand.  The correlation of true risk of 
cardiac death and HRA-based estimates of risk of cardiac death ranged from 0.145 to 0.800, with 
0.000 being worthless, and 1.000 being perfect.  The two morbidity- (illness) based HRAs had 
correlation scores of 0.800 and 0.763, respectively.  LDI-HRA is a morbidity-based system.  Thus, 
in a crowded HRA marketplace, the morbidity-based HRAs distinguished themselves in terms of 
validity.  The LDI-HRA, the first of the morbidity-based HRAs, has also distinguished itself by its 
documented efficacy and its sensibly balanced approach to the needs of participants, physicians, and 
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payers.  The HRA includes age specific and gender specific questions from which the response data 
generates an individualized Personal Health and Vitality Guide.  Complementary tools include 
Health Risk Summary Sheet, Report Card and aggregate Corporate Vitality Reports for the group.  
These components are serial, both for the individual and the group, and are designed to track 
changes over time.  Subsequent response data is measured, compared and linked with the prior data.  
Changes are shown in percentile risk scores and in the individualized paragraphs.  Over 15 essential 
categories such as biometrics, screenings, lifestyle health habits, etc. are analyzed to create 
participants’ risk profiles based upon diet, exercise, stress and other factors that inhibit current 
physical and mental activities and increase risk of future illnesses.  It is important to note that 
although sequential administrations are useful measures of individual change, baseline 
administrations (or once only analyses) also offer meaningful opportunities to assess individual and 
group risk factors.  The information can also be very valuable to respondents who are unaware of 
the severity of their current health status. 
 
Biometrics:  Blood Pressure, Glucose, and Lipids Biometric tests are important measures of 
health status and are routinely performed by licensed healthcare practitioners.  For this study, a 
licensed Pharmacist conducted the assessments in the pharmacies during the interview and testing 
process.  These lab values/readings are important components of the overall health risk assessment 
algorithm.    
Blood Pressure was measured using the Auscultatory Method.  A mercury-gravity reader 
and blood compression cuff was used with a stethoscope over the brachial artery to read systolic and 
diastolic blood pressure.  Current JNC VII and American Diabetes Association (ADA) blood 
pressure goals are <140/90 mm Hg or <130/80 mm Hg for patients with diabetes or chronic kidney 
disease. 
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Hypertension, most commonly referred to as high blood pressure, is a major determinant of 
cardiovascular disease.  The relationship between blood pressure and risk of cardiovascular events is 
continuous, consistent, and independent of other risk factors.  The Seventh Report of the Joint 
National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood 
Pressure (current JNC VII) guidelines report that for individuals 40-70 years of age, each increment 
of 20 mm Hg in SBP (Systolic Blood Pressure) or 10 mm Hg in DBP (Diastolic Blood Pressure) 
doubles the risk of CVD (Cardiovascular Disease) across the entire blood pressure range from 
115/75 to 185/115mm Hg.  In persons older than 50 years, Systolic Blood Pressure (SBP) >140 
mm Hg is a much more important CVD risk factor than Diastolic Blood Pressure (DBP).     
Glucose and lipid values are obtained directly from a blood sample.  Cholestek kits, which 
were used in this study, are among the most widely used population based testing products currently 
on the market.  Blood samples are collected from the subject’s fingertip, requiring only a small drop 
of blood to calculate glucose, LDL, HDL, and Triglycerides.  Normal glucose concentration in the 
blood is 80 to 120 mg/dl.  Normal/desirable total cholesterol value is <200 mg/dL.  
Normal/desirable LDL value is <130 mg/dL.  Normal/desirable HDL value is >35 mg/dL.  
Normal/desirable triglyceride value is <150 mg/dL.  These measures were recorded by the 
Pharmacist who conducted the screenings and were communicated privately to the subjects for 
sharing with their doctors. 
   
 Weight and Height    Weight and height measures are variables assessed for inclusion in the 
health risk assessment, (Physical Health Section of the HRA, items 2 and 3).  These measures are 
utilized in the Lifestyle Directions (LDI) algorithm to assess overall risk.  Individuals who are 20% 
to 30% over average weight for their age, sex, and height are considered obese.  This information is 
desirable but not essential for accurate assessment of risk. 
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 Rating of adherence pharmacy record   By agreeing to participate in this study, each subject 
provided consent for his/her pharmacy profile/history to be examined and documented within the 
parameters specified in the consent form.  This entailed a chart review of the subject’s pharmacy 
record to determine the prescriptions indicated for the control of hypertension that the subject had 
received within the previous 6 to 12 months.  Because there is more than one class of drugs used for 
this purpose, it was necessary for the pharmacist to identify the universe of appropriate medications 
for examination.  A list of the NDC codes for those medications with a documented, FDA approved 
indication for lowering blood pressure was compiled and used by the pharmacist who was 
conducting the chart reviews.  The pharmacist asked the subjects if they were currently taking 
medications for blood pressure control (antihypertensive), and if so, which medications.  The 
subjects were also asked to indicate the time when they were told initially by their physicians that 
they had high blood pressure (hypertension) as well as the time when they were first prescribed 
medications to control their blood pressure.  The pharmacist recorded the subjects’ responses on the 
spreadsheet and examined the patients’ medication refill histories to determine the fulfillment ratio 
for their hypertension medications.  The ratio was calculated by dividing the number of days 
dispensed (# of pills ÷ dosage) since first prescription by the number of days since first prescription.  
For purposes of this study, a ratio = 1 was interpreted as 100% adherence.  Any ratio of <1 was 
interpreted as less than fully compliant.  It was anticipated that the lower the fulfillment ratio, the 
higher the relative Blood Pressure of the subjects would be. 
 
Procedure 
 
Assembly of packets 
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  Measures and forms were assembled into identical packets, consisting of the following 
materials necessary for each subject:  (1) Informed Consent; (2) Health Adherence Behavior 
Inventory (HABIT); (3) Health Risk Assessment (HRA); (4) Subject Ticket for incentive drawing; 
and (5) Investigator assistant checklist of all necessary measures and dates of completion.  (see 
Appendices A, B, C, and E)   The checklist was provided for the pharmacist’s benefit so that he 
and/or his assistants could quickly review each subject’s packet for completion prior to data entry.  
Each packet, including all papers within the packet, was sequentially numbered to ensure that each 
respondent’s data was confidential, yet were accurately captured and recorded in a consistent and 
ethical manner.  A total of 300 packets were prepared. 
  
Questionnaire Development 
  Through a comprehensive collection and review of relevant literature, the authors of the 
HABIT identified and selected the appropriate domains which were to be used.  Items were chosen 
to represent the universe of non-adherent risk behaviors affecting health outcomes.  The investigator 
solicited independent expert review to ensure that the domains adequately represented the universe 
of non-adherence.  The expert panel was composed of two psychologists and two physicians, 
including an internist and a family physician.  The final item pool of all potentially relevant and 
appropriate questions were refined and developed. (Appendix B)   Experts were asked to place items 
in clear and understandable domains, (e.g., verbal monitoring) retaining only those items upon 
which 100% agreement was achieved.  The questionnaire was developed and the items were 
randomly ordered. 
 
Site Selection 
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 A suitable population in which pharmacy claims data was accessible (such as a pharmacy) 
was identified, and three pharmacies were selected to screen and assess subjects.  It was essential that 
the selected sites offered private screening areas where subjects could be interviewed and tested.  It 
was also important that the subjects received all of their hypertension medications from the same 
pharmacy.  The three pharmacies were owned and operated by a licensed Pharmacist in the State of 
Georgia, with additional licensure to perform cholesterol and glucose screening tests.  Approval and 
cooperation by the identified organization was obtained to solicit subjects for participation in this 
study prior to initiating the study.  The pharmacy was responsible for soliciting patients for 
participation, explaining the informed consent, performing the appropriate blood screening, weight 
and height measurements, ensuring that all questionnaires were completed, and examining and 
recording the subjects’ prescription refill records.   
 The investigator developed a poster (Appendix D) to solicit participation and enrollment, as 
well as a Question and Answer Instruction Sheet (Appendix E) to which the pharmacist might refer 
when answering questions from interested patients.  A consent form (Appendix A) was also 
developed to ensure informed consent was documented.  A health risk assessment was selected for 
inclusion in the data (Appendix C).  To facilitate participation, the investigator selected and offered 
an incentive to be offered to study participants.   
 IRB approval from Philadelphia College of Osteopathic Medicine was obtained.  
 
 
Subject Recruitment 
 Two weeks prior to beginning the study, the principal investigator met with the pharmacist 
and his assistant in order to train them on the administration of the surveys; this was done to ensure 
complete understanding of the procedure.  At that time, 300 packets which were prepared by the 
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investigator were provided to the Pharmacist (100 packets per pharmacy) ; a recruitment poster 
(Appendix D) was placed in each pharmacy indicating the nature, requirements, and timing of the 
study, along with a description of the incentive to participate.  During this two week period, the 
pharmacist was instructed to use the Question and Answer Instruction Sheet (Appendix E) to 
respond to questions from prospective subjects.  This form helped to ensure a consistent recruitment 
process by enabling the pharmacist and assistants to answer similar questions in the same manner.  
Within 2 weeks of placing the posters in the pharmacies, the Pharmacist advised the Investigator that 
pharmacy customers asked numerous questions, indicating that the posters and communication 
about the study were achieving the objective of generating interest about the study. 
 Once the study officially began, the potential subjects were randomly recruited (every 3rd 
eligible patient) from all patients who presented at the pharmacy with a prescription for hypertension 
over a 5 month period.(LASTING OVER A 5 MONTH PERIOD?   HAD BEEN GETTING THE 
PRESCRIPTION FOR 5 MONTHS?) When a patient presented at one of the three pharmacies with 
an appropriate prescription, the individual was asked by the pharmacist or assistant if he/she would 
be interested in participating in the study.  If the patient responded positively, the 
pharmacist/assistant probed the patient with additional questions to determine the individual’s 
appropriateness for inclusion in the study.  Interviews and tests were conducted in a private room 
within the pharmacy.   
 
Subject Testing 
 After the pharmacist/assistant was assured that the subject met the study inclusion criteria, 
the subject received one of the packets with an Informed Consent Form explaining the study, a 
Health Risk Assessment, a Health Adherence Behavior Inventory (HABIT), a ticket for the 
incentive drawing, and biometric screenings (lab work).  Each subject who agreed to participate in 
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the study was required to complete the HABIT and the Health Risk Assessment (HRA) 
questionnaire after signing the consent form.  The investigator at the pharmacy site was responsible 
for ensuring that the questionnaires were answered completely.  All data was gathered by the 
pharmacist and an assistant who was blinded to the study.  Following completion of the 
questionnaires, the subject submitted to a full lipid panel and blood pressure screening, as well as 
height and weight measurement.  The cholesterol test involved a tiny prick of the subject’s finger to 
obtain a small blood sample.  The sample was analyzed for cholesterol, glucose, and triglycerides.  
All blood testing, weight, and blood pressure measures were performed by a licensed healthcare 
provider at the pharmacy (satisfactory licensure documentation was provided to the principal 
investigator prior to initiation of the study).  The healthcare provider shared results of the screening 
with the subject and offered general interpretation of the results.  Subjects were provided with a 
hardcopy of their lab values and encouraged to share these results with their primary care 
physicians.  Specific questions concerning lab results were referred to the subjects’ physicians.  
Although all subjects were encouraged to share the results of their screening with their physicians, 
any subject whose results indicated that an urgent referral to a physician was warranted, would have 
been asked permission for the pharmacist to communicate directly with the subject’s physician by 
telephone to communicate their results.  No results were obtained which warranted such actions.   
Completion both of questionnaires and lab work took approximately 30 minutes for each subject.   
 Upon the receipt of completed materials, the pharmacist / assistant reviewed the responses 
for completeness, segregating those that were incomplete from completed questionnaires.  When the 
pharmacist or assistant was satisfied that all items were complete, the subject was thanked for his or 
her cooperation and given a copy of the lab results.   
 
Data Entry and Reporting 
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 All data from completed questionnaires and lab work was entered into a spreadsheet 
database by an assistant blinded to the study.  The HABIT and the Health Risk Assessment (HRA) 
were pre-numbered to correspond with each other (one unique identifier per questionnaire per 
subject which was administered at the same time).  Responses from the HABIT and the HRA were 
entered by the pharmacy investigator assistant into a spreadsheet template which was provided to the 
pharmacy study site prior to the beginning of the study.  Upon completion of the study, the 
pharmacist investigator assistant made copies of all questionnaires as well as copies of the completed 
spreadsheet containing all responses.  One copy of all materials remained with the pharmacy until 
completion of the study, at which time they were to be destroyed.  Each subject who agreed to 
participate in the study was required to complete both the HABIT questionnaire and the Health Risk 
Assessment after signing the consent form.   
 Completed HRA questionnaires were bulk shipped from the Pharmacy to LDI (Lifestyle 
Directions, Inc, Pittsburgh, PA.) for analysis.  The vendor processed each HRA and provided the 
pharmacy assistant with individual HRA (%) scores for each participant.  The subject was identified 
only by subject number.  The HRA percentile (%) risk scores given by LDI to the pharmacy 
assistant were added to the spreadsheet database.  LDI also generated individual reports for the study 
participants.  This report, “the Personal Health and Vitality Guide”, provided a customized health 
status report for each subject based upon his or her responses to the HRA.  The health status reports 
were sealed in confidential envelopes and bulk shipped to the pharmacy for confidential distribution 
by the pharmacist during the patient’s next visit to the pharmacy.  The envelopes containing the 
personalized health status reports were opened only by the study participant.  No identifiable 
personal information from these questionnaires or reports was shared with the pharmacist or his 
staff.   This completed all data collection for this study.   
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 The completed spreadsheet database was provided to the study investigator for final analysis.  
Responses from both questionnaires were compared with each other and with biometric measures of 
hypertension, cholesterol, glucose, and weight, as well as with the pharmacy records of refill for the 
identified prescription.   
 
 
 
 
 
Statistical Analysis 
Data for this psychometric study were collected and entered into a database (SPSS, Version 
12.0).  Descriptive statistics were examined.  All data was analyzed, including frequency 
distribution, mean, median, standard deviation, and standard error.  A Principal components 
varimax rotated factor analysis, and Cronbach’s coefficient alpha reliability analysis, including 
corrected item total score correlation, correlation of scores on instrument, and various psychometric 
parameters were calculated.   
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CHAPTER 3 
 
RESULTS 
 
This study was conducted over the 5 month period, from January 1, 2004 through May 30th, 
2004.  A total of 93 subjects completed all requisite questionnaires and biometric screenings.  All 
subjects were randomly selected from a population of hypertensive patients who presented with an 
antihypertensive prescription to be filled at one of 3 pharmacies in the metro Atlanta, Georgia area.  
Each subject was currently diagnosed with hypertension and fulfilled the study inclusion criteria of 
having an existing prescription for antihypertensive medication for a minimum of 6 months prior to 
entering the study.   In all, 89 (95.6%) of the subjects had been diagnosed with hypertension for 
more than 12 months and 4 subjects had been diagnosed with hypertension for between 6 and 12 
months.  English was the first language of each subject and all subjects were able to read at a 
minimum 8th grade reading level, in accordance with study inclusion criteria.   Participation was 
voluntary, and a signed, informed consent was obtained from each subject.  Subjects could remove 
themselves from the study at any time.  Also, in accordance with exclusion criteria, none of the 
subjects who completed the study was institutionalized, hospitalized, or currently participating in 
any other studies or disease management programs.   
Data collected for this study were entered into the statistical software SPSS (Statistical 
Program for the Social Sciences, version 12.0).  The database was doubled keyed to ensure accuracy 
and statistics were computed for all variables.  The following tables and discussion represent the 
final results and include the descriptive statistics and relevant factor analyses which address the 
variables of interest and hypotheses of this study. 
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Descriptive Statistics 
Of the 93 subjects who volunteered to participate in this study, 17 subjects were males 
(18.3%) and 76 subjects were females (81.7%).  A total of 73 (78.5%) of the subjects were 
Caucasian, 12 (12.9%) were African-American, and 8 (8.6%) were classified as “Other”.    The 
average age of this population was 59.5 years.  The majority of subjects, 62 (66.6%), had completed 
at least a high school education and within this group 28 (30.1%) also completed some level of 
college or beyond.   Of those who reported marital status, there were 20 (21.5%) married individuals 
in the study, 18 (19.4%) divorced subjects, 22 (23.7%) single subjects, and 29 (31.2%) 
widows/widowers.   Three of the subjects (3.2%) were working on a full-time, permanent basis.  The 
majority of subjects (58.1%) had previously retired and the remaining (38.79%) participants were 
otherwise employed or disabled.   All 93 subjects were insured with both medical and 
pharmaceutical health benefits.  Of these, 48 (51.6%) had a benefit that required less than a $30 co-
pay to fill a prescription; 36 (38.7%) had a co-pay benefit requiring less than a $20 co-pay per 
prescription refill.  The remaining 9 subjects had no co-pay for prescription drugs. 
 
Responses to the HABIT 
 
All 93 subjects (100%) in this study fully completed the Health Behavior Inventory 
(HABIT), as well as biometric screenings.  The HABIT consists of 50 items that describe ordinary 
health behavior “habits”, such as getting annual physical exams, wearing sunscreen, exercising and 
using seatbelts.  Subjects responded “true” if the described behavior generally matched their own 
behavior and “false” if they disagreed that the described behavior was similar to their own.  Table 1 
represents the frequency distribution of all variables (50 items) included on the HABIT.   Three 
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items identified are reverse scored, meaning that for a particular behavior, a positive response is 
“false”.  These statements/behaviors include “People tell me I am a Couch Potato”; I do not take 
prescribed medicines as directed”; and “I eat meals while doing other things.”    If a subject agreed 
with these statements and responded “true”, the behavior would not be considered a “positive health 
behavior”.  Rather, this would be considered a “negative health behavior”, and analyzed 
accordingly.  
All items are presented in descending order of positively endorsed response.  From this data 
it is clear that nearly all (96.8%) of the subjects reported that they followed their physicians’ advice.  
Specifically, they reported that they tended to keep their physician appointments, were punctual, 
obtained ordered medical tests, and filled their prescriptions promptly.  Items less frequently 
endorsed included behaviors related to exercise, such as taking stairs over elevators/escalators 
(25.8%); practicing relaxation or meditation exercises (32.3%); lifting weights (10.8%); and 
jogging (3.2%).  This may be related to the relatively older average age of the study group (59.5 
years), which implications are discussed later in more detail. 
 
Biometric Results 
 Biometric screenings were conducted by a licensed healthcare practitioner for each subject, 
including blood pressure, total blood cholesterol, high-density lipoproteins (HDL), low-density 
lipoproteins (LDL), triglycerides, and glucose (random or fasting).  These values were immediately 
communicated to the subject by the practitioner.  There were 10 subjects in whom the systolic blood 
pressure was above 160 and/or the diastolic blood pressure was above 90; these subjects were 
queried thoroughly about their “normal” blood pressure readings, their medications, and the 
frequency of their physician visits.  Similarly, in 36 subjects whose total blood cholesterol measures 
exceeded 200, and/or LDL values were obtained higher than 170, participants were asked additional 
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questions to assess urgent risk.   This additional assessment involved questions related to diet (in 
particular, immediately prior to the screening to assess accuracy of reading), as well as to existing 
medication regimen, and to the patient’s last physician encounter.  If, in the pharmacist’s 
professional opinion, the lab results warranted immediate follow-up for the patient, the pharmacist 
would have asked the patient for permission to speak with his/her physician.  However, based upon 
these subjects’ responses, it was determined that none of the lab values obtained by the healthcare 
provider were considered to present an immediate danger to the subjects; therefore, no call from the 
pharmacist to the subject’s physician was warranted.  However all subjects were strongly 
encouraged to share their lab results with their primary care physicians for follow-up.    
 Tables 2 and 3 provide the Systolic and Diastolic blood pressure values, frequency 
distributions, and cumulative percentages for all subjects tested.  The Systolic Blood Pressure was 
found to be significantly negatively correlated to the HABIT , (-.177*), i.e., the lower the systolic 
blood pressure the higher the HABIT score. 
 The additional biometric measures referenced in Table 4 were not specific to the study 
hypotheses.  Only hypertension, (blood pressure ratios), were metrics of interest for this adherence 
study.  However, the lab values for cholesterol, triglycerides, and glucose were important metrics for 
calculating the subject’s overall health risk and were desirable for more accurate processing of the 
Health Risk Assessment.  Table 4 provides the minimum, maximum, mean, and standard deviation 
for all biometric measures. 
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Table 1 
Health Adherence Behavior Inventory, Frequency Distribution 
 
                      Behavior 
 
Percentage with positive response 
Keep doctor’s appointments I make 98.9% 
Arrive on time for physician appointments 98.9% 
Obtain tests when ordered by a physician 96.8% 
Get medication prescriptions from physician filled promptly 96.8% 
Take a logical approach to problem solving 94.6% 
Take prescribed medications for recommended period 94.6% 
Follow advice of physicians 93.5% 
Follow doctor’s advice on health matters 93.5% 
Wear seat belts in cars 92.5% 
Take all medications as directed by doctor 92.5% 
Get routine physical exams 92.5% 
Sit in non-smoking public places 90.3% 
Avoid excessive use of alcohol 89.2% 
Able to keep a realistic view of stresses 89.2% 
Do not chew tobacco 88.2% 
Successfully cope with most stresses 88.2% 
Routinely examine skin for unusual markings 83.9% 
Limit amount of fat in diet 83.9% 
Try to eat low cholesterol foods 83.9% 
Avoid cigarette smoke 82.8% 
Limit amount of caffeine consumed 82.8% 
Limit salt intake 82.8% 
Avoid people who smoke 81.7% 
Eat enough fruits and vegetables 79.6% 
Examine breasts or testicles for lumps 79.6% 
Limit amount of sugar in diet 78.5% 
Try to sleep at least 8 hours each night 76.3% 
Get enough emotional support if stressed 76.3% 
Usually eat 3 meals a day 73.1% 
Drink low fat or skimmed milk 72.0% 
Watch calories carefully 71.0% 
Go to bed at a regular time each night 69.9% 
Get enough rest each night 69.9% 
Test smoke alarms regularly 68.8% 
Ask friends not to smoke in my presence 66.7% 
Avoid napping during the day 64.5% 
Am physically active 62.4% 
Avoid fast food restaurants 60.2% 
Weigh myself on a regular basis 60.2% 
Avoid snacking between meals 53.8% 
Exercise on a regular basis 50.5% 
Prefer to walk rather than drive if possible 47.3% 
Wear sun screen on sunny days 35.5% 
Eat meals while doing other things 34.4% 
Practice formal relaxation or meditation exercises 32.3% 
Take stairs over elevator/escalator 25.8% 
Do not take prescribed medicines as instructed 14.0% 
Lift weights 10.8% 
Am told by people that I am a “couch potato” 9.7% 
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Jog or run 3.2% 
 
 
Table 2 
Systolic Blood Pressure Values, Frequency Distributions, and Cumulative Percentages 
 
Systolic Blood 
Pressure 
Frequency Percentage Cumulative Percent 
108 2 2.1% 2.1% 
110 2 2.1% 4.2% 
118 6 6.5% 10.7% 
120 2 2.1% 12.8% 
122 5 5.4% 18.2% 
124 2 2.1% 20.3% 
126 1 1.1% 21.4% 
128 3 3.3% 24.7% 
130 6 6.5% 31.2% 
132 7 7.5% 38.7% 
134 1 1.1% 39.8% 
136 2 2.1% 41.9% 
138 9 9.7% 51.6% 
140 9 9.7% 61.3% 
142 4 4.3% 65.6% 
148 4 4.3% 69.9% 
150 4 4.3% 74.2% 
152 3 3.3% 77.5% 
154 2 2.1% 79.6% 
158 5 5.4% 85.0% 
160 2 2.1% 87.1% 
162 2 2.1% 89.2% 
164 2 2.1% 91.3% 
168 2 2.1% 93.4% 
170 3 3.3% 96.7% 
172 1 1.1% 97.8% 
185 1 1.1% 98.9% 
189 1 1.1% 100.0% 
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Table 3 
Diastolic Blood Pressure Values, Frequency Distributions, and Cumulative Percentages 
 
Diastolic Blood 
Pressure 
Frequency Percentage Cumulative Percent 
50 2 2.2% 2.2% 
60 2 2.2% 4.4% 
62 2 2.2% 6.6% 
64 3 3.2% 9.8% 
68 2 2.2% 12.0% 
70 4 4.3% 16.3% 
72 9 9.7% 26.0% 
74 5 5.3% 31.3% 
75 3 3.2% 34.5% 
76 4 4.3% 38.8% 
78 7 7.6% 46.4% 
80 16 17.1% 63.5% 
82 11 11.7% 75.2% 
84 4 4.3% 79.5% 
86 4 4.3% 83.8% 
88 5 5.3% 89.1% 
90 4 4.3% 93.4% 
94 2 2.2% 95.6% 
96 2 2.2% 97.8% 
100 2 2.2% 100.0% 
    
 
 
 
Table 4 
Biometric measures of Blood Pressure, Cholesterol, Triglycerides and Glucose, Minimum, 
Maximum, Mean and Standard Deviation 
 
Measure    Minimum Maximum Mean                      Standard 
            Deviation 
Systolic BP 108 189 138.2 21.2 
Diastolic BP 50 100 78.8 8.6 
Total Cholesterol 109 460 195.9 47.8 
HDL 20 91 49.6 15.4 
LDL 31 209 100.8 36.1 
Triglycerides 30 650 224.8 101.5 
Glucose 64 284 130.0 44.8 
 
 
Responses to the Health Risk Assessment (HRA) 
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As previously mentioned, the validated Health Risk Assessment by Lifestyle Directions, Inc. 
(LDI) was utilized in this study to establish construct validity for the HABIT questionnaire.   
Individuals who are at greater risk for disease score higher on the HRA than low risk respondents.  
This is reflected in an “Overall Health Risk” percentile score.  The questionnaire includes 113 
items, including a comprehensive medical history, dietary habits, personal habits, laboratory values, 
medication usage, and attitudes on health.  The overall “health risk” score is calculated using the 
Lifestyle Directions proprietary algorithm, which provides a relative measure of the respondent’s 
likelihood of developing or exacerbating serious health conditions and compromising quality of life.  
A total of 89 subjects (95.7%) completed all items on the HRA.  A few individuals did not respond 
to all items.  The items most frequently missed included waist and hip measurements, attitudes on 
exercise, and attitudes towards health in general.  These missing data do not compromise the 
integrity of the overall health risk score.   The algorithm is designed to account for these missing 
responses.   
Table 5 provides the frequency distribution of all subjects’ responses to the medical history 
portion of the HRA.  In this section subjects are asked if they or anyone in their immediate families 
(parents or siblings) has/had the specified diseases or conditions, which may predispose the 
individual to develop similar symptom(s) or condition(s).  Consistent with national averages, the 
most prevalent conditions included various forms of heart disease, diabetes, and musculoskeletal 
disorders.  This is particularly noticeable in a population such as this in which the average age was 
59.5 years.  Over 33% (31) of the subjects also reported depression, for themselves and/or in their 
immediate families, including 24 subjects (25.8%) who indicated that they were depressed 
themselves.  Data is presented in descending order of frequency of overall prevalence within 
families.  Although hypertension is not specifically referenced in the Health Risk Assessment as an 
independent diagnosis, the association between hypertension and other conditions such as 
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hyperlipidemia, heart disease and stroke is well established.  Thus the prevalence of these conditions 
would not be unexpected in a population which was designed to include subjects with a diagnosis of 
hypertension.   
Table 6 provides, in descending order, the frequency distribution of all subjects’ responses to 
the HRA questions related to dietary habits.  Subjects were asked to report how many servings of the 
listed foods they ate in a typical day; the possibilities ranged from 1 to 5 servings.  Greater 
consumption of fruits, vegetables and fiber, combined with lesser consumption of fats, oil, salt and 
sweets, contributes to a reduced risk for serious disease.  A minimum of 2 servings per day per 
category is considered significant in the HRA algorithm.   
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Table 5  Health Risk Assessment (HRA) 
Medical History, Frequency Distributions, and Percentages  
 
Disease Subject who reported Disease in 
Self, Parent or Sibling 
Percentage Subject reported 
condition in self 
Percentage 
Heart Attack 88   94.6% 85 91.4% 
Arthritis 66 70.9% 55 59.1% 
High Cholesterol 48 51.6% 43 46.2% 
Diabetes 42 45.2% 24 25.8% 
Heart Disease 41 44.1% 17 18.3% 
Back Pain 40 43.0% 36 38.7% 
Stroke 36 38.7% 16 17.2% 
Allergies 33 35.5% 28 30.1% 
Depression 31 33.3% 24 25.8% 
Thyroid Disease 31 33.3% 24 25.8% 
Osteoporosis 26 27.9% 23 24.7% 
Gallstones 23 24.7% 15 16.1% 
Skin Cancer 22 23.6% 14 15.1% 
Heart Failure 21 22.5% 6 06.5% 
Lung Cancer 16 17.2% 1 01.1% 
Migraine 16 17.3% 10 10.8% 
Alcoholism 15 16.1% 6 06.5% 
Emphysema 14 15.1% 4 04.3% 
Alzheimers 12 13.0% 2 02.2% 
Asthma 11 11.8% 7 07.5% 
Breast Cancer 10 10.7% 3 03.2% 
Kidney Disease 10 10.7% 4 04.3% 
COPD 9 9.7% 5 05.4% 
Hepatitis 9 9.6% 6 06.5% 
Rectal Polyps 9 9.6% 6 06.5% 
Other Cancer 8 8.6% 3 03.2% 
Colon Cancer 7 7.5% 3 03.2% 
Seizures 7 7.5% 3 03.2% 
Stomach Cancer 6 6.4% 1 01.1% 
Drug Dependency 5 5.4% 3 03.2% 
Parkinsons 4 4.3% 0 0% 
Liver Disease 3 3.2% 2 02.2% 
Uterine Cancer 3 3.3% 2 02.2% 
Prostate Cancer 2 2.2% 1 01.1% 
Ovarian Cancer 1 1.1% 0 0% 
AIDS 0 0% 0 0% 
Liver Cancer 0 0% 0 0% 
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Table 6  Health Risk Assessment (HRA) 
Dietary Habits, Frequency Distributions, and Percentages  
 
Food Category Minimum 2 servings/day Percentage 
Fiber 76 81.7% 
Vegetables 61 65.6% 
Meat, Fish, Poultry, Beans 48 51.6% 
Fruits 48 51.6% 
Breads, Cereals, Rice, Pasta 45 48.4% 
Dairy (milk, yogurt, cheese) 43 46.2% 
Fats, Butter, Oils, Sweets 40 43.0% 
Salt  12 12.9% 
   
 
In addition to dietary habits, subjects were asked on the HRA to report their use of tobacco, 
including cigarettes and all other forms, such as chewing tobacco, pipe, etc.  Reported tobacco use 
was minimal, with 71 (88.8%) subjects reporting no tobacco use of any kind and 9 (9.6%) 
respondents indicating less than one/half a pack per day.  When asked about former habits, 24 
subjects (25.8%) reported being former smokers; the average time since quitting was 13.5 years 
(across all 24 subjects).   
Other information captured on the HRA included details related to existing medications 
taken by the subjects.  Table 7 presents, in descending order, data on medication usage; it also 
includes a list of chronic diseases, and the medications necessary to control those diseases.  Subjects 
were asked to check all conditions for which they currently take (or are advised to take) 
medications.   
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Table 7 
Health Risk Assessment (HRA) Medication Usage Frequencies and Percentages 
 
Disease/Condition  Number of Patients current taking 
medication 
Percentage 
Hypertension 
High Cholesterol 
93 
37 
100.0% 
39.8% 
Arthritis 31 33.3% 
Calcium Supplement 27 30.3% 
Diabetes 23 24.7% 
Thyroid Condition 21 22.8% 
Back Pain 18 19.4% 
Digestive Problems 15 16.3% 
Heart Problems 15 16.1% 
Osteoporosis 12 13.0% 
Allergies 7 7.5% 
Asthma 7 7.5% 
Lung Problems 5 5.4% 
Seizure 4 4.3% 
Weight Control 2 2.2% 
   
 
Items which focused on stress levels, exercise, sleep, and preventive health habits were also 
included on the HRA.  Because this instrument is designed to project an accurate assessment of the 
respondents’ risks for negative health consequences, the level of detail and questioning concerning 
adherence to preventive health tests is extensive.  The HRA section which captures preventive 
screening exams includes periodic tests such as mammograms, prostate exams, colonoscopies, etc.  
Table 8 displays the respondents’ self-reported history of preventive exams for colorectal disease. 
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Table 8  Health Risk Assessment (HRA) 
Frequency of screening, percentage, and cumulative percent of exams for colorectal disease 
 
Colorectal Cancer 
Screening 
Frequency Percentage Cumulative Percent 
Within last year 22 23.7% 23.7% 
1 year ago 5 5.4% 29.1% 
2 years ago 
3-5 years ago 
Over 5 years ago 
Never 
8 
17 
6 
35 
 
8.6% 
18.3% 
6.5% 
37.5% 
37.7% 
56.0% 
62.5% 
100.0% 
 
As Table 8 shows, 44% of respondents indicated that they had not complied with national 
guidelines for obtaining a colon cancer screening test within the previous 5 years (based upon 
average age of respondents).  Interestingly, all 93 (100%) respondents reported a fecal occult blood 
test within the previous 5 years, suggesting that perhaps the less invasive test is considered 
equivalent, and thus other tests (?) are avoided.   Similarly, only 42 (47.2%) of the subjects 
indicated they had been screened for Diabetes within the prior 24 months, in spite of the fact that 
over 45% reported a history of diabetes within the immediate family.  Tables 9 through 12 provide 
frequency, percentage and cumulative percent regarding adherence to additional screening 
guidelines specific to older men and women, including last mammogram, cervical exams, prostate 
cancer screening, and self exams for which nationally recommended guidelines currently exist.  The 
mammogram and self-exam screening procedures reflect greater compliance rates of the more 
unpleasant screening exams such as pap smears and prostate exams.  
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Table 9  Health Risk Assessment (HRA) 
Preventive Mammogram, Frequency Distributions, and Cumulative Percentages 
 
Last Mammogram Frequency Percentage Cumulative 
Percent 
Within last year 42 56.8 56.8 
1 year ago 9 12.2 69.0 
2 years ago 10 13.4 82.4 
Over 3 years ago 9 12.2 94.6 
Never 4 5.4 100.0 
    
 
Table 10  Health Risk Assessment (HRA) 
Preventive Pap Exam, Frequency Distributions, and Cumulative Percentages 
 
Last Pap Smear Frequency Percentage Cumulative 
Percent 
Within last year 23 31.1 31.1 
1 year ago 17 23.0 54.1 
2 years ago 11 14.8 68.9 
Over 3 years ago 20 27.0 96.0 
Never 3 4.1 100.0 
 
 
Table 11  Health Risk Assessment (HRA) 
Preventive Prostate Cancer Screening, Frequency Distributions, and Cumulative Percentages 
 
Last Prostate Exam Frequency Percentage Cumulative 
Percent 
Within last year 8 50.0 50.0 
2 years ago 1 6.2 56.2 
Over 3 years ago 5 31.3 87.5 
Never 2 12.5 100.0 
 
Table 12  Health Risk Assessment (HRA) 
Preventive Self Exam (Breasts/Testicles), Frequency Distributions, and Cumulative Percentages 
 
Last Self Exam Frequency Percentage Cumulative 
Percent 
Monthly 48 51.6 51.6 
Every few months 18 19.4 71.0 
Rarely/Never 20 21.5 92.5 
Don’t Know 7 7.5 100.0 
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As captured in the HRA data, 56 (60.2%) of the subjects reported that they engaged in some 
form of exercise at least 3 times each week.  Of these, 44 (47.3%) indicated that they exercise for at 
least 20 minutes per exercise session.  The exact nature or definition of exercise was not captured.  A 
more specific exercise question on the HRA, such as strength training, was endorsed by 19 subjects 
(20.4%).   
Overall, a total of 90 participants (97.8%) reported on the HRA that they always use their 
seatbelts.  Of those who responded to a similar question of safety behavior on the HRA, 23.2% said 
they sometimes drive more than 10 miles over the speed limit.   
With respect to sleep, 54 subjects (58.0%) reported on the HRA that they slept fewer than 8 
hours per night.  Alcohol consumption was minimally endorsed, with 86% of respondents to the 
HRA indicating no use of alcohol, and of those who did endorse consumption, 100% indicated at 
least 2 drinks per occasion.   
Regarding anxiety, 40.5% of respondents to the HRA reported feeling anxious at least 2-3 
times per week, but 76.3% endorsed “getting enough emotional support if stressed”. 
 
Factor Analysis of the HABIT 
In order to perform a factor analysis of all 50 items on the HABIT questionnaire, the 
original study protocol planned to recruit 300 subjects into the study (a multiplier of 6).  At the end 
of a 4 month recruiting period, a total of 93 subjects had completed participation in the study.  
Although this was fewer than desired, the cost of recruiting and testing 93 subjects exceeded 
$11,000.  The original budget of $10,000 was based upon six weeks of estimated time and labor by 
the pharmacist and his staff.  In consideration of the time, difficulty, and considerable cost of 
recruiting additional subjects, it was jointly decided to end the study with a total of 93 subjects.  
Such a limited number of subjects precluded establishing construct validity readily because of low 
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subject to item ratio.  It was therefore determined that an initial inverse cluster analysis would be 
performed to determine Average Linkage between Groups.  
The hypothesis presumed that the HABIT questionnaire would produce 8 distinct domains 
related to non-adherence.  Because of the problem with the subject to item ratio, cluster analysis was 
used as an alternative to Factor Analysis of the HABIT.  Using the Average Linkage Between 
Groups Method, cluster analysis was restricted to 8 clusters.  During the cluster analyses the 
investigators discovered that 2 interpretable clusters emerged (Cluster 1 with 36 items and Cluster 8 
with 3 items).  When the clusters were identified, scores were calculated for the clusters, which were 
treated as 2 domains.  Cluster scores were determined for each subject.  There were then 2 scores for 
each subject, resulting in an acceptable subject to item ratio.  A principal components varimax 
rotated analysis according to Kaiser’s criterion was performed.  The two clusters merged into one 
higher order factor, leading the investigators to the conclusion that Cluster 1 and Cluster 8 loaded on 
a single “HABIT Factor”.  The HABIT cluster analysis is displayed in Table 13. 
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Table 13 
HABIT Cluster Analysis 
Case 8 Clusters 
Avoid people who smoke 1 
Try to sleep 8 hours 1 
Avoid cigarette smoke 1 
Watch calories carefully 1 
Test smoke alarms regularly 1 
Obtain tests ordered by my doctor 1 
Take logical approach to problem solving 1 
Examine skin for unusual markings 1 
Wear seat belts in cars 1 
Take all prescriptions as directed by doctor 1 
Eat enough fruits and vegetables 1 
Get enough emotional support if stressed 1 
Limit amount of caffeine consumed 1 
Usually eat 3 meals a day 1 
Avoid excessive use of alcohol 1 
Ask friends not to smoke in my presence 1 
Limit sugar intake 1 
Get prescriptions filled promptly from doctor 1 
Drink low fat or skimmed milk 1 
Examine breasts or testicles for lumps 1 
Get routine physical exams 1 
Successfully cope with most stresses 1 
Keep doctor’s appoints I make 1 
Follow advice of my physician 1 
Limit amount of fat in diet 1 
Able to keep a realistic view of stresses 1 
Am on time for doctor appointments 1 
Take prescribed medication for recommended period 1 
Sit in non-smoking public places 1 
Try to eat low cholesterol foods 1 
Follow doctor’s advice on health matters 1 
Limit salt intake 1 
People tell me I am a couch potato 1 
Do not take prescribed medicines as instructed 1 
Go to bed at regular time each night 1 
Get enough rest each night 1 
Avoid napping in day 2 
Weigh myself on a regular basis 2 
Eat meals while doing other things 3 
Lift weights 4 
Take stairs over elevator or escalator 4 
Don’t chew tobacco 4 
Jog or Run 4 
Practice formal relaxation/medication exercises 5 
Wear sun screen on sunny days 5 
Avoid fast food restaurants 6 
Avoid snacking between meals 7 
Exercise on a regular basis 8 
Prefer to walk rather than drive if possible 8 
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Am physically active 8 
 
As displayed in Table 13, Cluster 1 included 36 items.  The reliability coefficient of Cluster 
1 was .6953 (Chronbach’s Alpha).  Items in this Cluster, referred to as the overall Prevention 
Cluster, included preventive health habits such as performing routine self exams, getting sufficient 
sleep, avoiding tobacco products, eating low fat diets and limiting intake of salt, alcohol, and 
caffeine.  Items related to coping with stress and following instructions (particularly physician’s 
orders) were also included. 
Cluster 8 (the second interpretable Cluster), referred to as the Exercise Cluster, included 3 
items that were focused on physical exercise, i.e. “I exercise on a regular basis”, “I prefer to walk 
rather than drive if possible”, and “I am physically active”.  The reliability coefficient of Cluster 8 
was .6505 (Chronbach’s Alpha).   
 Collectively, these 39 items represent a Higher Order Factor.  Both Clusters and the Higher 
Order Factor revealed a significantly negative correlation with the Overall Health Risk score derived 
from the HRA.  This leads to the conclusion that the higher the HABIT score, (or the more positive 
health behaviors that the subject endorses), the lower his/her overall health risk and the less likely 
he/she is to experience hospital stays or to have high blood pressure or other diseases.  Specific 
correlations between the HABIT and overall health risk (HRA % Risk Score) are displayed in Table 
14. 
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Table 14 
Pearson Inter-correlations between the HABIT, Health Risk Score, Adherence Ratio, and Number of Medications 
  
  
 HRA% 
Risk Score 
 
CLUS 1 
 
CLUS 8 
 
ADHRATIO 
HRA % Risk Score Pearson Correlation 
 Sig. (1-tailed) 
 N 
 
 1 
 . 
           77 
    -.388** 
     .000 
        77 
  -.400** 
    .000 
      77 
      -.054 
        .321 
          77 
CLUS 1 Pearson Correlation 
 Sig. (1-tailed) 
 N 
    -.388** 
     .000 
        77 
         1 
         . 
       93 
    .398** 
    .000 
       93 
      -.139 
       .092 
          93 
CLUS 8 Pearson Correlation 
 Sig. (1-tailed) 
 N 
  -.400** 
    .000 
      77 
    .398** 
    .000 
      93 
         1 
         . 
       93 
      -.123 
       .121 
         93 
ADHRATIO Pearson Correlation 
 Sig. (1-tailed) 
 N 
      -.054 
        .321 
          77 
      -.139 
       .092 
          93 
      -.123 
       .121 
         93 
         1 
         . 
       93 
NUMMEDS Pearson Correlation 
 Sig. (t-tailed) 
 N 
       -.088 
        .228 
          74 
       .048 
       .328 
         87 
     -.047 
      .334 
       87 
        .119 
        .136 
         87 
HIORDRNU Pearson Correlation 
 Sig. (1-tailed) 
 N 
      -.437** 
       .000 
         77 
     .970** 
     .000 
       93 
    .610** 
    .000 
      93 
     -.153 
      .072 
        93 
 
CLUS 1 = Prevention Cluster 
CLUS 8 = Exercise Cluster 
ADHRATIO = Adherence Ratio 
NUMMEDS = Number of Medications taken 
HIORDRNU = Higher Order Factor 
HRA % Risk Score = Overall Health Risk result from HRA 
 
** Correlation is significant at the 0.01 level (1-tailed). 
  * Correlation is significant at the 0.05 level (1-tailed). 
 
 
As seen in Table 14, Cluster 1 (representing 36 items identified as the Prevention Cluster) is 
significantly, negatively correlated (-.388**) to overall Health Risk (HRA % Risk Score).  This 
strong negative correlation was anticipated on the intuitive hypothesis that a lower risk for disease 
and/or poor health would be associated with increasingly positive preventive health behaviors 
(higher score on the HABIT).  This is consistent with the increasingly significant negative 
correlations between Cluster 8 (representing 3 items identified as the Exercise Cluster) and the HRA 
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Overall Health Risk Score (-.400**), and the derived Higher Order Factor (HIORDRNU) with the 
HRA Overall Health Risk Score (-.437**). 
Examining the relationship between the Higher Order Factor of the HABIT and the HRA 
Overall Health Risk Score, it is possible to interpret the fact that approximately 19% of the 
variability in health risk assessed by the Lifestyle Direction’s Health Risk Assessment (HRA) is 
attributable to differences in health behaviors as measured by the Health Adherence Behavior 
Inventory (HABIT).   
 
Correlation between the HABIT, the Health Risk Assessment and Biometric Variables 
 It was predicted that a negative correlation would be reflected between the number of self-
reported, positive health behaviors on the HABIT and blood pressure level recorded on the Health 
Risk Assessment.  This hypothesis was partially supported by a significant negative correlation 
between Systolic Blood Pressure and the Higher Order Factor of (-.177*) at a 0.05 significance level 
(1-tailed), suggesting that the more positive health behaviors an individual endorses (as reflected on 
the HABIT), the lower his/her systolic blood pressure.  Table 15 highlights significant correlations 
between the HABIT and other variables, including biometric measures and self-reported data offered 
by the Health Risk Assessment (HRA).  Most notable in these statistics is a significant negative 
correlation (-.247**) between the HABIT Factor and self reported servings of fats, butter, oil, and 
sweets in a typical day.   The subjects who endorsed more healthy behaviors on the HABIT were 
less likely to consume excessive calories in fatty foods.  There was also a strong negative correlation 
between the HABIT Factor and feeling anxious, (-.304**).  The more frequently the individual 
reported that he/she was anxious, the less likely he/she was to endorse positive health behaviors 
presented in the HABIT.  A similar significant correlation (-.391**) was found between the HABIT 
Factor and the respondent’s last reported colorectal screening exam.  Additional similarities were 
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observed between numerous items on the HRA and the HABIT, with statistically significant 
correlations.  These similarities are presented more fully in the Discussion of this study. 
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Table 15 
Correlations of HABIT with Health Risk Assessment and Biometric Variables 
 
 HABIT Cluster 1  HABIT Cluster 8 HABIT Higher Order 
Current self rating Pearson Correlation 
of health Sig. (1-tailed) 
 N 
 -.158 
 .066 
 93 
 -.252** 
 .008 
 92 
 -.158 
 .066  
 92 
Current weight self Pearson Correlation 
reported Sig. (1-tailed) 
 N 
 .071 
 .255 
 89 
 -.220* 
 .019 
 89 
 .071 
 .255 
 989 
No. days hospitalized Pearson Correlation 
for injury in past Sig. (1-tailed) 
12 months N 
 -.158 
 .079 
 81 
 .199* 
 .037 
 81 
 -.158 
 .079 
 81 
No. days went to ER Pearson Correlation 
due to injury in past Sig. (1-tailed) 
12 months N 
 -.216* 
 .025 
 82 
 .177 
 .056 
 82 
 -.216* 
 .025 
 82 
Systolic Blood Pearson Correlation 
Pressure Sig. (1-tailed) 
 N 
 -.177* 
 .049 
 93 
 .117 
 .136 
 93 
        -.177* 
          .049 
             93 
No. Servings fats, Pearson Correlation 
butter, oil, sweets Sig. (1-tailed) 
in typical day N 
 -.289** 
 .003 
 90 
 -.054 
 .308 
 90 
         -.289** 
           .003 
            90 
Consumption of Pearson Correlation 
fiber in diet Sig. (1-tailed) 
 N 
 -.248** 
 .008 
 93 
 -.051 
 .314 
 93 
         -.248** 
          .008 
            93 
Last screening Pearson Correlation 
for colorectal Sig. (1-tailed) 
cancer N 
  -.391** 
 .000 
 89 
 -.228* 
 .016 
 89 
        -.391** 
          .000 
           89 
Avg times per Pearson Correlation 
week exercise Sig. (1-tailed) 
 N 
 .251* 
 .012 
 80 
 .426** 
 .000 
 80  
         .251* 
         .012 
            80 
Avg times per Pearson Correlation 
week strength Sig. (1-tailed) 
training N 
 .163 
 .140 
 46 
 .256* 
 .043 
 46 
         .163 
         .140 
           46 
How often Pearson Correlation 
you feel Sig. (1-tailed) 
anxious N 
 -.304** 
 .004 
 74 
 -.328** 
 .002 
 74 
       -.304** 
         .004 
           74 
Avg No. Pearson Correlation 
cigarettes Sig. (1-tailed) 
Per day N 
 -.346** 
 .001 
 80 
 -.266** 
 .009 
 80 
       -.346** 
          .001 
            80 
Currently Pearson Correlation 
taking Rx Sig. (1-tailed) 
for Diabetes N 
 -.178* 
 .044 
 93 
 .002 
 .492 
 93 
        -.178* 
          .044 
            93 
Currently Pearson Correlation 
taking Rx Sig. (1-tailed) 
for Thyroid N 
 -.190* 
 .044 
 93 
 -.161* 
 .061 
 93 
         -.190* 
           .044 
             93 
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CHAPTER 4 
 
DISCUSSION 
 
Considerable time and effort has been dedicated to the study of non-adherence and to the 
implications of this issue for all stakeholders in the healthcare delivery system.  The vast majority of 
research studies have focused on attempting to understand and to define the key influencers of this 
phenomenon.  This knowledge has demonstrated utility in the development of specific interventions 
which appear to improve adherence, under certain circumstances for various subsets of the 
population.  Translating this knowledge into a comprehensive set of questions that represent discrete 
domains of non-adherence has proven to be more challenging.  Given the complexity of the issue of 
non-adherence and the number of factors that may influence a particular patient at any given point in 
time, it is not surprising that no reliable instrument has yet been developed to predict, with any 
accuracy, a given individual’s likelihood of adhering to his or her prescribed treatment by a 
healthcare provider.  As such, the HABIT represents a new approach to addressing this challenging 
issue and the first of its kind to attempt to predict non-adherence based upon a universe of behaviors 
not previously observed to be related statistically.  The principal research question for this study was 
the viability of developing a brief questionnaire which could be used to predict the relative degree of 
adherence by a patient with his/her physician’s treatment orders.  This was the first study to examine 
the validity of the Health Adherence Behavior Inventory as a reliable instrument for this purpose.  
The investigators of this study hypothesized that similar patients who are not compliant with 
prescribed treatment regimens, specifically adherence to medication, would be identifiable by a 
profile of behavioral characteristics captured through a systematic approach of questioning with self-
reported responses to a dichotomous questionnaire.   
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The findings of this study are interesting because they offer support for the hypothesis that a 
finite number of items may ultimately be isolated to offer a practical and efficient approach to 
prospectively identifying patients whose health outcomes may be compromised by suboptimal 
treatment adherence.  The Health Adherence Behavior Inventory offers additional insight about the 
specific types of behaviors that appear to be related consistently to overall health.  The results 
presented in this study suggest that healthier patients do, indeed, engage in or refrain from certain 
behaviors which collectively reveal a pattern of habits that correlate significantly with their 
individual degrees of health risk.  The individuals who endorse greater the number of positive health 
behaviors have lower individual overall health risks.  Based upon this finding, it would be logical to 
expect that the relative risk of poor health would also be correlated significantly with the patient’s 
adherence to medication, as measured by an adherence rate or possession ratio.   Simply stated, 
medication adherence would be viewed as a positive health habit.  Thus the less compliant patients 
are with treatment (taking their medications), the greater their risk of serious illness and the less 
likely they are to endorse other positive health habits.  Interestingly, data from this study did not 
reveal a statistically significant relationship between the Health Risk Score as calculated by the 
Health Risk Assessment and the overall medication adherence ratio.  No significant correlation 
between the HABIT and overall medication adherence ratio was observed.  However, results of this 
study did reveal that the HABIT was significantly negatively correlated with a measure of systolic 
blood pressure at the 0.05 significance level (-.177*) and significantly negatively correlated at the 
0.01 significance level with an overall health risk score as measured by the Health Risk Assessment 
(-.437**).  The higher the individual scored on the HABIT, the lower their recorded systolic blood 
pressure and the relative risk of disease.  Investigators concluded that approximately 19% of the 
variability of health risk was attributable to differences in health behaviors as measured by the 
HABIT. 
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Content Validity of the HABIT 
 
The Health Adherence Behavior Inventory was designed to possess content validity.  Prior to 
implementing the study, a panel of Physician Experts and Psychologists examined these items for 
relevance, clarity, and ease of understanding.  The Expert Panel members agreed to review the items 
and were given the opportunity to revise items.  All recommendations from the Expert Panel were 
integrated into the final list of items and resubmitted to the Panel for final review.  100% of the 
Panel agreed that these items adequately represented the domain of content related to adherence and 
health risk behaviors.  The Expert Panel included Robert DiTomasso, Ph.D, ABPP, Interim Chair, 
Department of Psychology, Director of Clinical Research, Philadelphia College of Osteopathic 
Medicine with 25 years of practice as a Psychologist in Primary Care; Harry Morris, D.O., MPH, 
with 4 years as Chair Family Medicine and Director of Family Medicine Residency at Philadelphia 
College of Osteopathic Medicine with over 20 years practice in Primary Care; James Gamble, M.D.; 
and Barbara Golden, Psy.D., Faculty with Department of Psychology, Philadelphia College of 
Osteopathic Medicine.  
 
Construct Validity of the HABIT 
 In order to establish construct validity, the HABIT questionnaire was administered 
concurrently with a well documented and validated Health Risk Assessment.  A strong correlation 
between these two instruments would suggest not only that the construct of the HABIT is sound 
insofar as the instruments are purported to have similar utility, but also that the HABIT measures 
what it is intended to measure.  The Health Risk Assessment algorithm produces a single overall 
health risk score.  This study found a significant correlation at the 0.01 significance level between 
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the health risk score and the HABIT.  Additionally, the study of the HABIT has yielded 2 interesting 
findings.  First, the HABIT questionnaire appears to capture one overall factor or dimension of 
health risk.  That is, the HABIT represents a single domain of health behaviors that are significantly 
correlated with risks for poor health.  Although this finding in itself does not offer a comprehensive 
set of the domains that influence non-adherence, the emergence of a single domain that correlates 
with health risk is important because non-adherence has been found consistently to be a significant 
contributor to poor health outcomes and elevated risks.  The link between blood pressure control, 
health risk, and medication compliance in a hypertensive population is well established.  Second, the 
absence of a statistically significant correlation between the HABIT and the recorded medication 
adherence ratio for these subjects raises worthwhile questions concerning methodological limitations 
of this study and introduces opportunities for refinement of the items in future research. 
 
Additional Findings Related to the Health Risk Assessment 
 As previously discussed, the Lifestyle Directions instrument is a widely used health risk 
assessment that has been extensively studied.  Thus other significant correlations were evident 
during this analysis on an item by item basis.   For example, individuals who reported their self 
ratings of current health status as good or excellent were significantly more likely to endorse positive 
health behaviors and experiences.  A positive correlation was noted between self report health status 
and satisfactory weight (.253**).  Positive health status also correlated with fewer days missed from 
work for illness (.226*), and less time spent in the Emergency Room due to illness (.316**).  
Subjects who viewed their current health status as positive responded that they watched their caloric 
intake (.208*) and exercised more frequently (.374*) than those who reported a poorer health status.   
A positive attitude about health also correlated with self reported preventive exams, such as 
colonoscopy (.463*).  
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 Overweight subjects were more likely to endorse poorer health habits, and indicated lower 
overall self ratings of their current health.  Being overweight was negatively correlated with each of 
the following behaviors:  exercise (-.303**), consumption of fruits and vegetables (-.185*), taking 
medication for hyperlipidemia (-.277**), and HDL, or good cholesterol (-.332**).  Being 
overweight was also positively correlated with alcohol consumption (.482*), diastolic blood pressure 
(.215*), and consumption of fats and sweets (.392*).   
 Waist circumference was positively correlated to several poorer indications of health, 
including higher number of visits to a physician (.427*), days hospitalized (.444*), Emergency 
Room visits (.593**), Systolic Blood Pressure (.518*), Total Cholesterol (.590*), and LDL (.608*).   
 The number of medications that an individual was taking correlated significantly with the 
frequency of physician visits (.647**), reflecting a greater need to see a doctor when on chronic 
medications.   Frequency of physician visits also correlated positively with the frequency of 
prescription refills (.217*), suggesting, perhaps, that the more an individual goes to the doctor the 
greater the likelihood that he or she will fill prescriptions.   
 Hospitalizations were significantly correlated with several biometric measures of acute 
health issues, including high triglycerides levels (.315**), fasting glucose levels, (.981**), and fat 
intake (.194*).  Negative correlations between frequency of hospitalizations and self-reported 
medication compliance were observed in the following disease conditions:  asthma (-.325**), heart 
conditions (-.201*), digestive disorders (-.208*), lung disease (-.385**), osteoporosis (-.222*), and 
smoking-.410*).   
 Systolic blood pressure was positively correlated with diastolic blood pressure (.306**), and 
random glucose (.248*).  A negative correlation between systolic blood pressure and health behavior 
was also observed, including a negative correlation with self reported compliance with diabetes 
medication (-.245*) and cholesterol prescriptions (-.203*).  Many participants who reported 
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currently taking medication to control blood pressure also reported higher servings of fats and sweets 
(.209*).   
 Diastolic Blood Pressure (DBP) was positively correlated to LDL, or bad cholesterol, at 
(.342**).  A higher DBP was also correlated with increased frequency of prescription (days 
prescribed) at (.219*).   Stated another way, those individuals with higher diastolic blood pressure 
readings were more likely to receive prescriptions. 
 HDL, or good cholesterol was negatively correlated to the following metrics:   
weight, (-.332*), waist circumference (-.494*), triglycerides (-.315*), and blood pressure ratio  
(-.961**).  Triglycerides were positively correlated to fat intake (.213*), blood pressure ratio 
(.893*), cholesterol (.471**).   
 Fasting glucose was significantly correlated to daily servings of cheese and dairy products 
(.874*).  Servings of fruit consumed daily was negatively correlated to weight (-.185*), waist 
circumference (-.511**), caloric intake (-.183*), fat intake (-.263**), and consumption of fiber   (-
.302**).  Fruit consumption was positively correlated to vegetable intake (.617**), dairy foods 
(.346**), and poultry and rice (.341**).  
 Fat intake was positively correlated with total caloric intake (.680**), as well as with the 
number of days prescribed medication (.319**).  Fat intake was also associated with frequently 
driving over the speed limit (.243*).  Fats and sweets intake was positively correlated with level of 
anxiety (.283**).  Total caloric intake was negatively associated with self reported compliance with 
cholesterol medication (-.278*) but positively correlated with the number of days prescribed 
medication (.197*).  Drinking alcohol was similarly associated with higher average weight (.575**).   
Those with higher reported fat intake endorsed higher caloric intake (.197*), and reported that they 
more frequently drove over the speed limit (.273*).   
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 Smoking was negatively correlated with resting pulse rate (-.763**) as was alcohol 
consumption (-.800**).  A negative correlation was found between the number of cigarettes per day 
and Cluster 1 of the HABIT (-.346**); significant correlation was also found between cigarettes and 
Cluster 8 of the HABIT (-.266*).   Cigarette smoking was negatively correlated with self reported 
medication compliance (-.234*), as well as with weight (-.575**).   
 There was a strong correlation between last mammogram and last pap smear (.356**) as 
well as the last pap smear and colonoscopy (.347*).  There was a negative correlation between 
anxiety and exercise (-.325*).  Preventive self exam of testicles was associated with higher 
prescription refill rates (.631**).  Self reported attitudes about exercise, stress, nutrition, weight, and 
drinking were all significantly correlated.  A positive attitude about stress and strong coping 
strategies were associated with healthier attitudes towards weight management (.413**), nutrition 
(.752**), exercise (.680**), smoking (.708**), and alcohol (.613**).  A positive attitude about 
exercise was associated with a positive attitude about smoking (.688**) and alcohol (.696**).  
Likewise, a positive attitude about nutrition and diet management was associated with a positive 
attitude towards exercise (.667**), stress (.752**), smoking (.706**), and alcohol (.649**).  
Certainty about maintaining health, or self efficacy, was negatively correlated with random glucose 
(-.276*), and fat intake (-.256*).  It was also positively correlated with preventive exams such as 
colonoscopy (.463**) and cancer screenings (.279*).   
 Those who reported currently taking medication to control cholesterol reported higher 
servings of fats and sweets (.184*).  These individuals also reported a greater number of medications 
for associated heart disease (.304**) and thyroid disease (.244**).   
 There were several correlations between individuals’ self reported compliance with asthma 
medications and other variables.  Specifically, individuals who reported that they that complied with 
asthma medication made fewer visits to the doctor (-.289**), made fewer visits to a hospital (-
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.325**), spent fewer days in the hospital (0.247**), experienced fewer days missed from work or 
other activities (-.262**), and made fewer trips to the Emergency Room (-.261*).  The more 
compliant the subjects were with asthma medications the more compliant they reported themselves 
with other medications, such as those for osteoporosis (.290**), lung disease (.655**), allergies 
(.537**), and weight control (.520**).   
A positive attitude about nutrition correlated to higher refills of prescriptions (.379**).  Less 
anxious individuals endorsed more positive health behaviors on the HABIT (-.304**), and less 
tobacco use (-.346**).  Total blood cholesterol was correlated to triglyceride levels (.893*), but 
negatively to HDL (-.315**), and positively correlated to fat intake (.213*).  HDL was negatively 
correlated to alcohol (-.654*), and certainty amount maintaining(???) health was correlated to 
random glucose (-.276*). 
These findings suggest the need for future research on related variables of interest. 
 
 
Internal Consistency of the HABIT 
In order to assess the internal consistency of the HABIT scores, Chronbach’s coefficient 
alpha reliability was calculated.  The coefficient alpha of the entire scale was .705.   
 
The Dimensions of Non-Adherence 
 The findings from this study of the HABIT appear to uncover two basic types of behaviors 
that are related to health risk.  The first set of behaviors is somewhat passive in nature; however, the 
second set of behaviors may be described as more proactive in nature.  For discussion purposes, the 
first cluster of statements is referred to as the “prevention cluster” and the second cluster of 
statements is referred to as the “exercise cluster”.  Behavior statements that were endorsed in the 
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prevention cluster included phrases like “avoid people who smoke”, “avoid excessive use of 
alcohol”, “avoid napping in the day”, “avoid fast food restaurants”, “ “avoid snacking”, “limit 
caffeine”, “limit sugar”, “limit fat”, “limit cholesterol foods”, and so forth.    Behaviors statements 
that were endorsed in the exercise cluster, though limited, included the phrases “I exercise on a 
regular basis”, “I prefer to walk rather than drive if possible”, and “I am physically active”.   Initial 
consideration was given to the value of interpreting these clusters as representing different “themes”.  
For example, could exercise be considered a more proactive behavior, requiring more motivation on 
behalf of the subject and therefore be more predictive, whereas avoidance behaviors require less 
effort?  With such small numbers, a reliable answer to this question could not be determined; 
however, the subtle difference suggests that further research to assess these behaviors as independent 
domains may be fruitful.  
 Collectively, based upon this sample size, both clusters were determined to represent a single 
factor or dimension of non-adherence, which was jointly referred to as the “HABIT Factor”; this 
factor was determined to account for 19% of the variability in health risk as calculated by the HRA.  
In an effort to understand how the behaviors reported on the HABIT were related to the Adherence 
Ratio, further investigation of the raw data revealed interesting findings with respect to certain 
responses.  Specifically, when the frequency distribution of the Days Fill Ratio (numerator and 
denominator) was examined, it was apparent that 83 of the 93 subjects (89.2%) had an 
antihypertensive prescription written for a full calendar year (365 days).  The remaining 10 subjects 
had a prescription written for at least 6 months.  Yet the corresponding prescription fill rate (number 
of days for which the patient actually had medication), was far less in most cases.  In fact, none of 
the subjects had sufficient medication for the entire prescribed period, and 34 patients (36.6%) had 
fill rates of less than 50%.  This information was reliable, based upon the pharmacy records and 
patients’ self-reported use of a single pharmacy for filling all prescriptions.  This is consistent with 
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the literature on medication adherence rates, but not generally considered acceptable for therapeutic 
efficacy.  Another 8 patients (8.6%) had filled their prescriptions 65.7% of the time, and 13 patients 
(13.9%) had a minimum supply of 270 days (73.9% Days Fill Ratio).  Roughly expressed, a 
handful of patients had missed only 2 days of medication each week, or 8 days per month, yet 
another 42 (45.1%) patients failed to take the prescribed medication between 34.2% and 100% of 
the time.   Less than 28% of the subjects missed fewer than 6 days per month medication.   
 Self-reported responses captured by the HABIT were not subject to verification; however, 
results indicated that 96.8% of the 93 subjects in the study reported that they got their prescribed 
medications filled promptly, and 94.6% of them indicated that they took prescribed medications for 
the recommended period.  When asked about following their doctor’s advice, 93.5% said they 
followed their doctors’ advice on matters related to their health. 
 One possible explanation for the observed discrepancy is a desire to “fake good”.  All of the 
participants in this study were, by definition, diagnosed with hypertension.  In addition, 85 of the 93 
subjects reported experiencing a previous heart attack.  One consideration is that this could represent 
a bias in the population which may be reflected in distorted perceptions of actual adherence.  Given 
that 83 of the subjects had been diagnosed with hypertension for more than a year, it is not 
unreasonable to assume that many of the subjects have had their blood pressures monitored by their 
physicians for some time.  In fact, they may well have had serious discussions with their physicians 
related to their conditions.  To admit that they were not taking medication or were not following 
their physicians’ advice might have resulted in cognitive dissonance and subsequent distorted 
perceptions of their own behaviors. 
The Health Risk Assessment does not contain items specific to medication compliance.  The 
respondent is simply asked to check from a list of conditions for which they are currently taking a 
medication.  The presence of a condition is utilized in the health risk algorithm, but compliance is 
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not.  Quantitative measures such as age, weight, and lab values weigh more heavily in the 
calculation than qualitative responses.  As a result, there is little opportunity to “fake good” on the 
Health Risk Assessment.    
As previously mentioned, numerous theories have been offered to explain why one person 
will adhere to his/her physician’s advice and another person will not.  Some of the factors proposed 
as influencing adherence include the nature of the condition or disease, the complexity of the 
treatment regimen, and individual psychological characteristics.  These theories are useful to 
establish hypotheses about the rationale for behavior, but the majority of research in this area does 
not expand on the types of behaviors observed by compliant or non-compliant patients.  The most 
common tool at the disposal of healthcare professionals and health insurance plans remains the 
retrospective claims analysis.  This type of automated analysis utilizes claims databases to identify 
diagnosed patients who, based upon quantitative data, appear to be non-adherent with medication or 
other prescribed treatment guidelines.  Interventions can then be targeted to these individuals, and 
often include case management, patient education or compliance reminder mailings, etc.   
Additional reasons posited for non-adherence are external or situational factors, such as the 
relative cost and the patient’s access to medical care.  Studies examining these factors contribute to 
the literature by offering additional insight into the dimensions and behavior which correlate with 
poor patient adherence and by offering further evidence that these factors correlate with overall 
health risk.  Further research with larger and more diverse study populations may support the 
development of a limited number of questions representing a comprehensive set of domains that 
correlate with non-adherence.  This may ultimately allow for the development of patient profiles that 
could facilitate the identification of critical targets for treatment in non-adherent patients.  In 
practice, if the instrument is refined, prudent use of the HABIT may enable the clinician to improve 
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therapeutic outcomes through earlier intervention in which patient behaviors may compromise 
overall treatment. 
 
Methodological Limitations of the Study 
 There are several limitations to the current study, including those that are specific to this 
study and those that are more universal.  In general, self-reports are influenced by the wording of the 
questions, content, and format.  As a result, the subjects who participated in this study may have 
interpreted the questions differently.  They may also have been more or less motivated to respond is 
ways that would be socially desirable.  The questions on the HABIT deal with personal health 
behaviors that may be associated with an individual’s perception of “character”.  The nature and 
structure of the questions and the relative transparency of the content make it possible to overstate a 
response, and thus increase (?) the overall degree of its importance.  There are no right or wrong 
answers and no direct way to assess the patient’s subjective state independently.  Bias and 
inaccuracy can be additionally compromised by the rapport with the clinician and by the physical 
conditions (such as medication or food immediately prior to a biometric screening).  
 Another limitation of this study concerns the demographics of the population.  The 
volunteers were, on average, older subjects and predominantly female.  This resulted in a higher 
than anticipated number of seniors whose health, based upon age alone, would be expected to be at 
greater risk for serious illness.  This was most evident in the percentage of individuals who reported 
a previous heart attack (91.4%).  The co-morbidities, health insurance benefits, and seriousness of 
overall health conditions reflected in this population would not necessarily be representative of the 
general population; this results in findings that necessitate further investigation. 
 These deficiencies negate neither the overall value of the HABIT questionnaire nor the 
relative contributions of this study.  The correlation between the HABIT and the Health Risk 
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Assessment suggest that the current version of the HABIT may provide a cost effective alternative to 
other assessments that are underutilized due to length, cost, and complexity. 
 By removing those items that do not load on the single habit factor, and by refining the 
remaining items into a smaller subscale, it may be possible to construct a more comprehensive 
questionnaire that addresses additionally relevant domains of non-adherence.  Specifically, several 
questions related to following physician’s advice and obtaining medication are similar in wording 
and the data from this study revealed nearly identical responses.  New research on application of the 
Transtheoretical Model and Health Belief Model is underway for the explicit purpose of developing 
interventions to improve adherence.  These studies are more narrowly focused on the concept of self-
efficacy and stages of change as they relate to distinct profiles of non-adherent individuals.  The 
relative utility of segregating persons of similar beliefs into categories of non-adherence, i.e. non-
adherers, partial adherers, and near-optimal adherers, may also provide additional insight as to the 
behavioral characteristics that make these groups unique.  Additionally, restructuring the HABIT 
questions into a Likert scale may offer greater sensitivity to capture subtle differences less evident in 
a dichotomous format. 
       
Implications for Research and Future Direction 
 It is clear that many factors operate to impact adherence and that these factors vary not only 
across demographics and individuals, but also across illnesses.  The reliability of future research 
may be challenged by errors of measurement that may take place due to problems such as 
inconsistency of examinees (e.g., motivation, interest, and attention), flaws in research design, 
testing site differences, and distractions.  Other challenges may necessitate modification of the items 
to lessen the transparency of questions.  One possibility is to utilize another instrument such as an 
acceptable measure of social desirability to assess the impact of this issue.   
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Conclusions 
  
The HABIT questionnaire shows promise in capturing reliable information that correlates with non-
adherence.  Specifically, a selection of self reported health behaviors appear to be linked to health 
risk in ways that offer partial explanations and predictions which account for variability in health 
outcomes.  These behaviors represent one dimension of non-adherence that is relatively easy 
information to collect and assess.  Numerous theories and research on non-adherence have proposed 
both internal and external factors as critically influential in determining treatment adherence.  
Further work is necessary to incorporate the learnings from this study into future research which 
applies theoretical concepts to expand the universe of predictable behaviors. 
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Addendum: Combination Drugs for Hypertension  
Combination Type  Fixed-Dose Combination, mg  Trade Name  
ACEIs and CCBs  Amlodipine/benazepril hydrochloride 
(2.5/10, 5/10, 5/20, 10/20)   
Enalapril maleate/felodipine (5/2.5, 5/5)   
Trandolapril/verapamil (2/180, 1/240, 
2/240, 4/240)  
Lotrel   
Lexxel   
Tarka   
  
ACEIs and diuretics  Benazepril/hydrochlorothiazide (5/6.25, 
10/12.5, 20/12.5, 20/25)    
Captopril/hydrochlorothiazide (25/15, 
25/25, 50/15, 50/25)    
Enalapril maleate/hydrochlorothiazide 
(5/12.5, 10/25) 
Lisinopril/hydrochlorothiazide 
(10/12.5, 20/12.5, 20/25)    
Moexipril HCI/hydrochlorothiazide 
(7.5/12.5, 15/12.5, 15/25)    
Quinapril HCI/hydrochlorothiazide 
(10/12.5, 20/12.5, 20/25)    
Lotensin HCT   
Capozide   
Vaseretic   
Prinzide   
Uniretic   
Accuretic  
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ARBs and diuretics  Candesartan 
cilexetil/hydrochlorothiazide (16/12.5, 
32/12.5)   
Eprosartan 
mesylate/hydrochlorothiazide 
(600/12.5, 600/25) 
Irbesartan/hydrochlorothiazide 
(150/12.5, 300/12.5)    
Losartan potassium/hydrochlorothiazide 
(50/12.5, 100/25)    
Olmesartan/hydrochlorothiazide 
(20/12.5, 40/12.5, 40/25)   
Telmisartan/hydrochlorothiazide 
(40/12.5, 80/12.5) 
Valsartan/hydrochlorothiazide (80/12.5, 
160/12.5, 160/25)    
Atacand HCT   
Teveten HCT   
Avalide   
Hyzaar   
Benicar HCT   
Micardis HCT   
Diovan HCT  
BBs and diuretics  Atenolol/chlorthalidone (50/25, 100/25)    
Bisoprolol 
fumarate/hydrochlorothiazide (2.5/6.25, 
5/6.25, 10/6.25)    
Propranolol/hydrochlorothiazide 
(40/25, 80/25)   
Propranolol LA/hydrochlorothiazide 
(80/50, 120/50. 160/50)   
Metoprolol tartrate/hydrochlorothiazide 
(50/25, 100/25, 100/50)    
Nadolol/bendrofluthiazide (40/5, 80/5)    
Timolol maleate/hydrochlorothiazide 
(10/25)    
Tenoretic   
Ziac   
Inderide   
Inderide LA   
Lopressor HCT   
Corzide   
Timolide  
Centrally acting drug and diuretic  Methyldopa/hydrochlorothiazide 
(250/15, 250/25, 500/30, 500/50)   
Reserpine/chlorothiazide (0.125/250, 
0.25/500) 
Reserpine/hydrochlorothiazide 
(0.125/25, 0.125/50)    
Aldoril   
Diupres   
Hydropres  
Diuretic and diuretic  Amiloride HCI/hydrochlorothiazide 
(5/50) 
Spironolactone/hydrochlorothiazide 
(25/25, 50/50) 
Triamterene/hydrochlorothiazide 
(37.5/25, 75/50)   
  
Moduretic   
Aldactazide   
Dyazide, Maxzide  
   
 
ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta-blocker; CCB = 
calcium channel blocker.   
Source: http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf; 9-12-03 and current PIs.   
 
 
